soft tissue sarcomas - guide for patients - japanese...soft tissue sarcomas: a guide for patients -...
TRANSCRIPT
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 1
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ïŒæ£è ããã®æåŒã
ESMO 蚺çã¬ã€ãã©ã€ã³ã«åºã¥ããæ£è ããåãæ å ±
æ¥æ¬èªèš³ççºè¡ã«ããã
ããæ£è ããã®æãåå®ãªèŠæã®äžã€ãããèªèº«ã®çœ¹æ£ããããã«é¢ããæ£ç¢ºãªæ²»çæ å ±ãåŸ
ãããšã§ããæ¥æ¬çæ²»çåŠäŒã§ã¯åçš®åŠè¡å£äœãçºåããããé¢é£èšºçã¬ã€ãã©ã€ã³ã®å ¬éãã
ãæ²»çå šè¬ã«é¢ãã暪æçããæ²»çæ¯æçæ³ã«é¢ãã蚺çã¬ã€ãã©ã€ã³ã®çå®ãªã©ãè¡ã£ãŠåã
ãŸãããäžéšã®ããã§ã¯æ£è ããããã®ã家æã«ãããããããäžè¬åããã®èšºçã¬ã€ãã©ã€ã³
ãçºåãããŠããŸãããããããç¶²çŸ ããé åã¯ãŸã ååãšã¯èšããªãç¶æ³ã§ãã
ããæ£è ããã«ãšã£ãŠæã倧åãªæšæºæ²»çã«ã€ããŠåããæã解説ããã¬ã€ãã©ã€ã³ãæäŸã
ãç®çã§ãæ¬åŠäŒåçäºé·ã®è¥¿å±±æ£åœŠå çãšåœæã®æ¬§å·èšåºè «çåŠäŒïŒEUROPEAN SOCIETY OF
MEDICAL ONCOLOGY, ESMOïŒäŒé· ROLF A. STAHEL å çãåæãããESMO/ANTICANCER
FUND GUIDES FOR PATIENTS æ¥æ¬èªèš³ããçºåããããšãšãªããŸãããæ¥æ¬ãšæ¬§å·ã§ã¯äœ¿çšå¯
èœãªæè «çè¬ãæè¡æ¹æ³ãªã©ãè¥å¹²ç°ãªããŸãããç æ ã®ç解ãæ²»çã®æµããªã©æ£è ããã«ãã
ãããã解説ããã蚺çã¬ã€ãã©ã€ã³ã¯å€§å€è²Žéãªæ å ±æºãšãªãããšãæåŸ ãããŸãããŸããæ¬
éŠã«ãããŠããããæ£è ããåãã®èšºçã¬ã€ãã©ã€ã³ãçºåããåŸæŒããšããªããæ£è ããåã
ã¬ã€ãã©ã€ã³ã®ããæ¹ã«ã€ããŠã倧å€åèã«ãªããã®ãšæåŸ ããŠãããŸããæ¬ã·ãªãŒãºã®ç¿»èš³ã
äœæã«å€å€§ãªããå°œåãé ããæ¥æ¬çæ²»çåŠäŒçäºãæè²å§å¡äŒãç·šéå§å¡äŒã®çæ§ãã¯ããã
ãæ¯æŽãäžãã£ããã¹ãŠã®çæ§ã«å¿ããæè¬ç³ãäžããŸãã
å¹³æ 29 幎 7 æ æ¥æ¬çæ²»çåŠäŒ
çäºé· åå·éå
ãã®åºŠãESMO ïŒæ¬§å·èšåºè «çåŠäŒïŒã®çºè¡ããâESMO GUIDES FOR PATIENTSâã
ãESMO æ£è ããã®æåŒãããšããŠæ¥æ¬èªèš³ããæ¥æ¬ã®çæ£è ããã«æäŸããããšã«ãªããŸã
ãã
æè¿ã®çæ²»çã®çºå±ã¯ãããŸãããçæ£è ããã«ãšã£ãŠã¯æ°å€ãã®æ²»çæ³ã®éžæãå¯èœã«ãªã£
ãŠããŠããŸããæ£è ããã«ãšã£ãŠã¯æå ±ã§ãããããããã£ãœãã§ã¯å€§éã«çºä¿¡ãããæ å ±ã®äž
ã§ãçã«æºããå»çåŸäºè ãšæ£è ãããšã®éã§ã®ç¥èã®ã®ã£ãããåé¡ã«ãªã£ãŠããŸããããµã
ãããæ å ±ã®äžã§ãçã«å¯Ÿããæ£ç¢ºãªæ å ±ãæŽçããèªåã«æé©ãªæ²»çæ³ãèŠã€ãåºãããšã¯æ¬
åœã«é£ããããšã§ããããšæããŸãããã®ãããªæ å ±ã®æµ·ã®äžã§è¿·ã£ãŠããçæ£è ããã«å¯Ÿãã
ã¬ã€ã圹ãšããŠããã®ãESMO æ£è ããã®æåŒããã¯äœæãããŠããŸãã
ãã®æåŒãã¯âESMO/ANTICANCER FUND GUIDES FOR PATIENTSâ ããåºæ¥ãã ãå¿ å®ã«
æ¥æ¬èªèš³ããããšã«ããŠãããŸãããšãŒããããšæ¥æ¬ã§ã¯ãä¿éºå¶åºŠãå«ãå»çäºæ ãè¥å¹²ç°ãª
ã£ãŠããŸãã®ã§ããã®æåŒãããã®ãŸãŸæ¥æ¬ã®æ£è ããã«åœãŠã¯ãŸããªãããšãããããšæããŸ
ããããå€æã«å°ãããšããããŸãããã䞻治å»ã®å çã«çŽæ¥ãèãããã ããã°ãšæããŸãã
ãã®æåŒããæ¥æ¬ã®çæ£è ããã«ãšã£ãŠæçšãªæ¡å 圹ãšãªãããšãæåŸ ããŠããŸãã
æåŸã«ããã®æåŒãã®äœæã«å°œåããã ããæ¥æ¬çæ²»çåŠäŒæè²å§å¡äŒããããŠç·šéå§å¡äŒã®å
çæ¹ã«å¿ããæè¬ããããšæããŸãã
å¹³æ 29 幎 7 æ æ¥æ¬çæ²»çåŠäŒ
ç·šéå§å¡äŒå§å¡é· å°å·ä¿®
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 2
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ïŒæ£è ããã®æåŒã
ESMO 蚺çã¬ã€ãã©ã€ã³ã«åºã¥ããæ£è ããåãæ å ±
翻蚳 åœç«ããç 究ã»ã³ã¿ãŒäžå€®ç é¢ïŒåžå°ããã»ã³ã¿ãŒ
骚è»éšè «çç§ïŒå°æè±ä»ã䞹沢矩äžãé è€èª
è «çå ç§ïŒäžäºèŸ°åŸ³
æ³å°¿åšã»åŸè ¹èè «çç§ïŒåå¶æå
ãã®æ£è ããçšæåŒãã¯ãæ£è ããããã®å®¶æãè»éšèè «ã®æ§è³ªãããç解ã§ãããã
ã«ããããŠåã ã®è»éšèè «ã«å¯Ÿããæãé©åã§æå¹ãªæ²»çãæ£ããéžæã§ããããã«ãæ£è
ãããžã®ãµãŒãã¹ãšããŠããå æåºéã«ãã£ãŠäœæãããŠããŸããæ£è ããã«ã¯ããèªèº«ã®
ç ç¶ãç æã«ãã£ãŠãã©ã®ãããªæ€æ»ãæ²»çãå¿ èŠã§ããããæ åœå»ã«å°ããŠããã ãããš
ããå§ãããŸããããã§è¿°ã¹ãããŠããå»çæ å ±ã¯ ESMO ã®è»éšèè «ã®åãæ±ãã®ããã®
蚺çã¬ã€ãã©ã€ã³ã«åºã¥ããŠããŸãããã®æ£è ããçšæåŒã㯠ESMO ã®ååã®ããšã§äœæ
ãããESMO ã®èš±å¯ã®ããšé åžãããŠããŸãããã®æåŒãã¯å»åž«ã«ããå·çãããå°éå»
åã蚺çã¬ã€ãã©ã€ã³ã®çé èè ãå«ããESMO æå±ã®äºåã®è «çå»ã«ãã£ãŠç£ä¿®ãåã
ãŠããŸãããŸããESMO ã®ããæ£è ã¯ãŒãã³ã°ã°ã«ãŒãã®ä»£è¡šè ã«ãç£ä¿®ãåããŠããŸ
ãã
ããå æåºéïŒAnticancer FundïŒã«é¢ããæ å ±ãæŽã«ç¥ãããå Žåã¯ä»¥äžã®ãµã€ããžã¢
ã¯ã»ã¹ããŠäžãã: www.anticancerfund.org
欧å·èšåºè «çåŠäŒïŒESMOïŒã«ã€ããŠæŽã«ç¥ãããå Žåã¯ä»¥äžã®ãµã€ããžã¢ã¯ã»ã¹ããŠäžã
ã: www.esmo.org
ïŒãä»ããçšèªã«é¢ããŠã¯ãå·»æ«ã«æ³šéããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 3
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç®æ¬¡
è»éšèè «ã«ã€ããŠã®ãŸãšã......................................................................................................................................... 4
è»éšèè «ã®å®çŸ© ................................................................................................................................................................. 5
è»éšèè «ã®é »åºŠã¯ïŒ ....................................................................................................................................................... 6
è»éšèè «ã®åå ã¯ïŒ ....................................................................................................................................................... 7
è»éšèè «ã®èšºæã¯ïŒ ....................................................................................................................................................... 9
æé©ãªæ²»çãåããã«ã¯äœãéèŠãïŒ ............................................................................................................ 11
æ²»çã®éžæè¢ãšããŠäœãããã®ïŒ ...................................................................................................................... 14
æ²»çã®å¯äœçšã®å¯èœæ§ãšããŠäœãããã®ïŒ ................................................................................................... 20
ããæ£è æ¯æŽå£äœã¯ã©ã®ããã«åã«ãªã£ãŠãããã®ãïŒ ...................................................................... 25
æ²»çåŸã«ã©ããªããšãèµ·ãåŸããïŒ ................................................................................................................. 27
çšèªã®èª¬æ ...................................................................................................................................................................... 28
ãã®ããã¹ã㯠Dr. Paolo Casali (ESMO)ãDr. Silvia Stacchiotti (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)ã Dr. Salvatore Provenzano (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)ã®ååã®ããšãDr. Vittoria Colia (for the Anticancer Fund) ã«ããå·çãããDr. Gauthier Bouche (Anticancer Fund)ãDr. Svetlana Jezdic (ESMO)ãJorge Freitas RNã MsC (EONS)ãJane Beveridge BSc Honsã MScã ããŒã¹ã»ã³ã³ãµã«ã¿ã³ã (EONS)ã Anita Margulies BSN RN (EONS)ã Markus Wartenberg (Sarcoma Patients EuroNet Association â SPAEN)ã Roger Wilson (SPAEN) ãProf. Jean-Yves Blay (ESMO)ã«ããç£ä¿®ãããŠããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 4
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ã«ã€ããŠã®ãŸãšã
è»éšèè «ã®å®çŸ©
è»éšèè «ãšã¯ãè»éšçµç¹ã«çºçããæªæ§è «çã°ã«ãŒãã®ããšã§ããè»éšçµç¹ã«ã¯ãçèã
è ±ãèèªãè¡æ¶²ããªã³ã管ãç¥çµãé¢ç¯å ãèŠãèç¶ã®çµç¹ïŒæ»èçµç¹*ïŒãå«ãŸããŸãã
è»éšçµç¹ã¯äœã®ã©ãã«ã§ããããããè»éšèè «ã¯å šèº«ã«çºçããå¯èœæ§ããããŸãã
蚺æ
æ®å¿µãªããšã«ãèè «*ã¯é·ãæéãçç¶ãçŸããŸãããçç¶ã¯çºçããäœã®éšäœã«ãã£ãŠ
ç°ãªããŸããäžè¢ãäžè¢ãäœå¹¹ã«ããããããããããšãã«ãªã£ãŠãããããèè «ã®å¯
èœæ§ãçãããããšã«ãªããŸãã
è»éšèè «ã®åºãããå€å®ããé é転移*ã®æç¡ã確èªããããã«æŸå°ç·æ€æ»*ãå¿ ãè¡ã
ãŸãã
æ€æ»å®€ã§åæããèè «*ã®ã¿ã€ãã«ã€ããŠãã¡ããšç¢ºèªããããã«ãè «çã®ãµã³ãã«ãæ¡
åããïŒçæ€*ïŒå¿ èŠããããŸãã
æ²»ç
å±åšæ§ã®èè «ã¯ãåçºéšäœã«ãšã©ãŸããåšå²ã®èåšã«æµžæœ€ã転移ã®ãªãç¶æ ã§ãã
o å€ç§æ²»çã§è «çãåé€ããããšãæšæºæ²»çã§ã
o æŸå°ç·æ²»ç*ãååŠçæ³*ã®åç¬ãŸãã¯äœµçšæ²»çããæè¡åŸã«å®æœããããšããããŸ
ããããã¯æ²»ççïŒæ²»ã確çïŒãé«ããåçºã転移ã®ãªã¹ã¯ãæžããç®çã§è¡ããŸ
ãã
o è «çãçž®å°ãããåé€ããããšã容æã«ããå®å šåé€ãå¯èœã«ããããã«ãè¡åã«
æŸå°ç·æ²»ç*ãè¡ãããšããããŸãã
èè «*ã®é²è¡äŸã¯ãçºçãããšããããäœã®ä»ã®éšåã«åºãã£ãç¶æ ã§ãããã¯ã転移äŸ
ãé²è¡äŸïŒé²è¡çïŒãšåŒã°ããŸãã
o äž»ãªæ²»çã¯ãååŠçæ³*ãšååæšççæ³*ãšãªããŸããæ£è ããã®èšåºç¶æ ãšèè «*çµ
ç¹äºåã«åãããè¬å€éžæãè¡ãããŸãã
o ååŠçæ³*ã®æäžãããã®åŸã«ãçç¶ç·©åã転移*ã³ã³ãããŒã«ã®ããã«æŸå°ç·æ²»ç*
ã䜵çšããããšããããŸã
o ããã€ãã®ç¹å®ã®çäŸã§ã¯ãçç¶ãç·©åããããããŸãã¯ããããæ²»çããããã«
æè¡ãè¡ãããšããããŸãã
çµé芳å¯
æ²»çåŸã®çµé芳å¯ã®èšºå¯ã«ã¯ã身äœèšºå¯ãè¡æ¶²æ€æ»ãæŸå°ç·æ€æ»ãå«ãŸãããããã®æ€
æ»ãæ°å¹Žéè¡ããŸãã
è»éšèè «ã®çµé芳å¯ã®æé©ãªã¹ã±ãžã¥ãŒã«ã¯ç¢ºå®ããŠããŸãããè «çã®äœçœ®ã倧ããã
æªæ§åºŠïŒã°ã¬ãŒãïŒã«ãã£ãŠæ±ºããããŸããäœæªæ§åºŠèè «ã«æ¯ã¹ãé«æªæ§åºŠãŸãã¯äžé
æªæ§åºŠè»éšèè «ã®æ²»çåŸã®çµé芳å¯ã¯ãããé »åºŠãé«ããªããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 5
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ã®å®çŸ©
è»éšèè «ãšã¯ãâè»éšçµç¹âãšâçµåçµç¹âã®äžã§ãç°åžžãªçŽ°èãçºçããå¶åŸ¡äžèœã«ãªã£
ãå Žåã«çããæ§ã ãªæªæ§è «çã®ç·ç§°ãšãªããŸããè»éšçµç¹ã¯ãäœã®ã©ã®éšåã«ããããç
èãè ±ãèèªãè¡æ¶²ããªã³ã管ãç¥çµãé¢ç¯å ç®çŽ°èïŒæ»èçµç¹*ïŒãªã©ã®çµç¹ãå«ãŸããŸ
ãã èè «*ã®ã¿ã€ãã¯ããã®èµ·æºãšãªã£ã现èã®çš®é¡ã«ããç°ãªããŸããçµåçµç¹ã«ã¯ãäœ
ã®äžã§ãç°ãªãçµç¹å士ãé£æºããããåé¢ãããããããã¹ãŠã®çµç¹ãå«ãŸããŸããã€ãŸ
ããäŸãã°ãããã¯åå®®ã®ãããªäœå ã®åšå®ã®æ§é ã®äžã«ãããŸããè»éšèè «ã¯ãäœã®ã»ãš
ãã©ã®éšäœã«çºçãåŸãŸããã奜çºéšäœãšããŠã¯äžè¢ãšäžè¢ïŒ50ïŒ ïŒã«æãå€ããç¶ããŠ
äœå¹¹ãšè ¹éšïŒ40ïŒ ïŒãé é žéšïŒ10ïŒ ïŒã®é çªãšãªããŸãã
èè «ã®ç¹æ®åã«é¢ããéèŠäºé
ã«ããžèè «*ãšæ¶å管éè³ªè «ç*ïŒGISTïŒãè»éšèè «ã§ãããä»ã®è»éšèè «ãšã¯æ²»çäœç³»ã
ç°ãªããŸãã®ã§ãæ¬æåŒãã§ã¯æ±ããŸããã
骚ã®èè «ã¯ã骚ã圢æãã现èããçãããã®ã§ã骚èè «*ãšãåŒã°ããŸãããŠãŒã€ã³ã°è
è «ã¯äžè¬ã«ã骚ã«çºçããçšãªçš®é¡ã®èè «ã§ãã骚èè «ãšãŠãŒã€ã³ã°èè «ã®æ²»çäœç³»ã¯ãè»
éšèè «ãšã¯ç°ãªããŸãã®ã§ãæ¬æåŒãã§ã¯æ±ããŸããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 6
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ã®é »åºŠã¯ïŒ
è»éšèè «ã¯çšãªè «çã§ãããšãŒãããã§ã¯ãæ¯å¹Ž 10 äžäººããã 4ã5 人ã蚺æãããåœã«
ãã£ãŠå€§ããªéãã¯ãããŸãããè»éšèè «ãçºçããç涯ãªã¹ã¯ã¯ãçŽ 0.15ã0.50ïŒ ã§
ããäžè¬ã«ãå°å ãããæ人ã«å€ãã50ïœ60 æ³ååŸãçºçã®ããŒã¯ãšãªããŸãããå šå¹Ž
霢局ã®æ¹ã«èµ·ããåŸãŸãã
è»éšè «çã¯çšãªçŸæ£ã§ãããå°é家ãé£æºããéåŠçæ²»ç*ãå¿ èŠãšããããšãã»ãšãã©ã§
ãããããè»éšèè «ã®æ²»çã¯ãã®ç æ°ã®ç¥èãæã€ãç çå»*ãæŸå°ç·ç§å»*ãå€ç§å»ãæŽåœ¢
å€ç§å»*ãæŸå°ç·è «çå»*ãè «çå ç§å»*ãå°å è «çå»*ãªã©ã®ããå°éæœèšã§è¡ãå¿ èŠããã
ãŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 7
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ã®åå ã¯ïŒ è»éšçµç¹èè «çºçã®çç±ã¯ããã£ãŠããŸããããããããã€ãã®ãªã¹ã¯ãã¡ã¯ã¿ãŒïŒå±éºå
åïŒã¯ç¢ºèªãããŠããŸããå±éºå åã¯ããã®çºçãªã¹ã¯ãé«ããŸãããå¿ ãæªæ§è»éšè «çã
çºçãããããã§ã¯ãããŸãããäžã€ã®å±éºå åã®ã¿ã§ã¯ãããåããŸããã
å±éºå åãæã€äººã§ããè»éšèè «ãçºçããªãå ŽåãããããŸããå±éºå åã®ãªã人ã«è»éš
èè «ãçºçããããšããããŸãã
è»éšèè «ã®äž»ãªå±éºå åã¯ä»¥äžãšãªããŸãã
- éºäŒççŽ å ïŒå 倩çãŸãã¯åŸå€©çãªéºäŒçç¶æ³ã®äž¡æ¹ã
è»éšèè «ã®çºçã«é¢é£ããå¯èœæ§ããããŸãã
o ãªãŒãã©ãŠã¡ãçå矀ã¯ã现èãçåãé²ãã®
㫠圹 ç« ã€ éº äŒ å 㧠ã ã è « ç æ å¶ éº äŒ å *
ïŒp53ïŒã®å€ç°*ã§èµ·ãã家ææ§ã®éºäŒåç°åžž
ã§ãããã®çšãªçå矀ã®æ£è ããã¯ãæªæ§è»éš
èè «ãå«ãæ§ã ãªæªæ§è «çãçºçãããããªã
ãŸãã
o 家ææ§è ºè «æ§ããªããŒã·ã¹ã¯ãè «çæå¶éºäŒå
*ã§ãã APCïŒå€§è žè ºè «æ§ããªããŒã·ã¹ïŒéºäŒå*ãå€ç°*ãèµ·ãããŠããã®ãç¹
城ã§ãã家ææ§è ºè «æ§ããªããŒã·ã¹ã®æ£è ããã¯ãäžè¬ã« 20 æ³ä»¥éãæ°çŸïœæ°
åã®çµè žããªãŒããã§ããŸããçµè žããªãŒãã¯ãå€§è žçã«å€åããå¯èœæ§ã®ãã
è¯æ§*è «çã§ãã家ææ§è ºè «æ§ããªããŒã·ã¹ã®æ£è ããã¯ãè ¹è å ãã¹ã¢ã€ãè «
çïŒè»éšçµç¹è «çã®äžçš®ïŒãé«é »åºŠã§çºçããŸãã
o ã¬ãŒãããŒçå矀ã¯ãéªšè «*ãé¡äžç®å¢è «*ãç·ç¶è «ãªã©ã®è¯æ§è «çã®çºçã«é¢é£
ãã家ææ§è ºè «æ§ããªããŒã·ã¹ã®äžçš®ã§ãã ã¬ãŒãããŒçå矀ã®æ£è ããã¯ãè ¹
è å ãã¹ã¢ã€ãè «çïŒè»éšçµç¹è «çã®äžçš®ïŒã奜çºããŸãã
o RBïŒç¶²èèœçŽ°èè «ïŒçå矀ã¯ãè «çæå¶éºäŒå*ã§ãã RB éºäŒå*ã®å€ç°ãç¹
城ãšãã家ææ§çå矀ã§ããæ£è ããã¯éåžžãå°å æã«äž¡çŒã®ç¶²èã«æªæ§è «çã
çºçããŸããæé·åŸã骚è»éšã®èè «ãçºçããããšããããŸãã
o ç¥çµç·ç¶è «ç IïŒãã©ã³ã¬ãã¯ãªã³ã°ããŠãŒã³ç *ïŒïŒãã®éºäŒæ§çŸæ£ã¯ãè «çæ
å¶éºäŒå*ã§ãã NF1 éºäŒå*ã®å€ç°*ãç¹åŸŽã§ããèšåºçã«ã¯ãç¥çµç·ç¶è «ãšã
ãŠç¥ãããŠããåºãç¯å²ã«èµ·ããè¯æ§*è «çãã«ãã§ãªã¬æ*ãªã©ç®èã®ç å€ãç¹
城ã§ãããã©ã³ã¬ãã¯ãªã³ã°ããŠãŒã³ç *ã®æ£è ããã¯ãæªæ§æ«æ¢¢ç¥çµéè «çïŒ
MPNSTïŒãçºçãããªã¹ã¯ãé«ããçšã«ãæ¶å管éè³ªè «çïŒGISTïŒ*ããã³æšª
çŽçèè «*ãçºçããŸãã
o ç¥çµç·ç¶è «ç IIïŒãã®çå矀ã¯ãè «çæå¶éºäŒå NF2 ã®çªç¶å€ç°*ã«ãã£ãŠåŒã
èµ·ããããŸããããã¯å žåçã«ã¯è³ãŸãã¯ä»ã®ç¥çµã«ãããèŽç¥çµã®ç¥çµéè «*
ãšé¢é£ããŠããŸããç¥çµç³»çŽ°èããçºçãã 2 ã€ã®ã¿ã€ãã®è «çãã€ãŸããé«è
è «*ãšç¥çµè è «ïŒã°ãªãªãŒãïŒ*ã®çºçãªã¹ã¯ããããŸãã
o åºç€çŽ°èæ¯æçå矀*ãçµç¯ç¡¬åç*ããŠã§ã«ããŒçå矀ãªã©ã®éºäŒççŸæ£ã¯ãè»
éšèè «ã®çºçãªã¹ã¯ã®å¢å ãšé¢é£ããŠããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 8
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
- é»é¢æŸå°ç·*ïŒé»é¢æŸå°ç·ã®è¢«ã°ãã¯ãä»ã®å±éºå åããªããŠãè»éšçµç¹èè «ã®ãªã¹
ã¯ãé«ããå¯èœæ§ããããŸããçšã§ãããä¹³ããããªã³ãè «ãªã©ã®ä»ã®ãããæ²»ç
ããããã®æŸå°ç·ç §å°åŸã«èè «*ãçºçããããšããããããã¯ãäž»ã«æŸå°ç·æ²»çã
åããäœã®éšåããå§ãŸããŸããæ²»çã®éãå¢ããã°ãªã¹ã¯ãå¢å ããŸããã幎霢
ãäžããã«ã€ããŠæžå°ããŸããæŸå°ç·æ²»çããèè «*ãšèšºæããããŸã§ã®æéã¯å¹³å
ããŠçŽ 10 幎ã§ããæŸå°ç·æ²»çãåå ãšããè»éšèè «ã¯ãéåžžã«çšã§ãã
- ååŠç©è³ªïŒè»éšèè «ã®å±éºå åãšããŠå€ãã®ååŠçºããç©è³ª*ã®ããšãèšåãããŠã
ãŸããããããã®é¢é£æ§ã®ã»ãšãã©ãæ確ã«ç¢ºç«ãããŠããŸãããå¡©åãããŒã«*ã
ãçŽ ãšèè*è¡ç®¡èè «ïŒè»éšèè «ã®äžçš®ïŒããã§ããã·ç³»é€èå€*ããã€ãªãã·ã³*ãš
è»éšèè «ã®çºçãšã®éã«é¢é£æ§ããããšãããŠããŸããåŽåã«ããæŽé²ã«æãé«ã
ãªã¹ã¯ããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 9
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
è»éšèè «ã®èšºæã¯ïŒ
èè «*ã¯é·æéç¡çç¶ã§çµéããããšãå€ãã倧ããæé·ããèåšãç¥çµãçèãå§è¿«ããŠ
ããçç¶ãåºãŠããŸããèè «ã¯äœã®ã©ã®éšåã§ãèµ·ããåŸãçºçéšäœã«ç¹æãªçç¶ãèµ·ãã
ãŸããèãè ãäœå¹¹ã«ãããããããããããšãäž»ãªçç¶ã§ãããŸããä»ã®ç æ°ã®èšºå¯ãæ
è¡ãåããŠãããšãã«ãããŸããŸçºèŠãããããšããããŸãã
以äžã®æ€æ»ã«åºã¥ããŠèè «*ã蚺æããŸãïŒ
1. ç æŽãšèšåºèšºå¯ã æ åœå»åž«ã¯ãæ£è ããã®ç æŽããã¡ããšç
解ãããããçç¶ããã€å§ãŸã£ãã®ããæéã®çµéãšãšãã«
ã©ã®ããã«å€åããã®ããå°ãããªã¹ã¯èŠå ããã§ãã¯ãã
ããšããå§ããŸããæ åœå»åž«ã¯ãè «ç€ãçã¿ãããå Žæã®èšº
å¯ã ãã§ãªããå šèº«ã蚺å¯ããŸããèè «*ãæ足ïŒåè¢ïŒã®ã
ãããã®éšåã«ããå Žåãæãäžè¬çãªçç¶ã¯äžå¿«ãªè «ãã§
ãããã®è «ãã«ã¯ãæã«çã¿ããå§çã䌎ãããšããããŸã
ããç¡çã®ããšããããŸããèè «*ãäœã®äžå€®éšïŒäœå¹¹ïŒã«ããå Žåãçç¶ã¯èåšããšã«
ç°ãªããŸããäŸãã°ãèºã®èè «*ã¯ãæ¯åããå³ãåŒãèµ·ããããšããããŸããè ¹éšã«ã§
ããããããè ¹çãååã䟿ç§ã®åå ãšãªãããšããããŸããåå®®ã§ããã°èè «ã«ããã
åå®®åºè¡ãäžè ¹éšçãäžæ£åºè¡ïŒæçµéãéçµåŸ*ïŒãªã©ãåŒãèµ·ãã
ããšããããŸãã
2. è¡æ¶²æ€æ»ãè¡æ¶²æ€æ»ã§ãæ£è ããã®å šèº«ç¶æ ããã§ãã¯ããèèãè èã
é è¡æ©èœã調ã¹ãŸãã
3. æŸå°ç·æ€æ»*ãäœå ã芳å¯ããŠè»éšèè «ã®çšåºŠãå€å®ããé é転移æ§çŸ
æ£ã®æç¡ã確èªããããã«ãæ§ã ãªç»åæè¡ã«ããæ€æ»ãè¡ãããŸãã
èžéšã¬ã³ãã²ã³*ïŒ èè «ã®è»¢ç§»ãæãå€ãèºã«ãèè «ãåºãã£ãŠ
ããããå€æããããã«çšããããåçŽã¬ã³ãã²ã³ã®ããšã§ãã
è¶ é³æ³¢æ€æ»ïŒé³æ³¢ãšãšã³ãŒæ³¢ã§ç»åãäœæããæ€æ»ã®äžã€ã§ããæ€æ»ãè¡ãäœã®éš
äœãæ€æ»ã®ç®çã«ãããæ§ã ãªçš®é¡ã®è¶ é³æ³¢*ã¹ãã£ã³ããããŸããè ¹éšã骚ç€å
ã«ããèèãè èããããã¯å¿æ©èœãæ€æ»ããããã«ã¯å€éšè¶ é³æ³¢ãå©çšããåå®®
ã«ã¯è£å ãããŒã*ãå©çšããŸããè¶ é³æ³¢å èŠé¡ã¯ãå èŠé¡ãšåŒã°ãããã¥ãŒãç¶
ã®éå ·ã䜿ããŸãããé³æ³¢ãå©çšããŠãè ¹éšã®åšå®ã®ç»
åãçæããŸãã
CT æ€æ»*ïŒã³ã³ãã¥ãŒã¿æå±€æ®åœ±ã¯äœã®å éšã®è©³çŽ°ãª
ç»åãçæããã¬ã³ãã²ã³*æè¡ã§ããå£è é 圱å€ãšã
ã液äœã飲ãã ããéèã«é 圱å€ãæäžããããšã§ãè
åšãçµç¹ãããæçã«èŠããããã«ãªããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 10
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
PET scanïŒPET scanïŒéœé»åæŸå°åæå±€æ®åœ±æ³ïŒã¯ãäž»ã«èè «*ãäœã®ä»ã®éš
åã«åºãã£ãŠãããã©ããã調ã¹ãããã«äœ¿çšãããŸããæ£è ããã«ã°ã«ã³ãŒã¹*
ãå«ãç©è³ªã泚å°ãæ€æ»ãè¡ããŸããã°ã«ã³ãŒã¹*ãå«ãæŸå°ç·æšèãããç©è³ªã¯ã
æ£åžžçµç¹ã«æ¯ã¹ããã现èã«åžåãããããæé€ããã«ãããããããçµç¹å ã«
ãéã蟌ãããããå¯èŠåãããç¶æ ãšãªããŸããPET scan ãå©çšããŠãæŸå°
ç·æšèãããã°ã«ã³ãŒã¹ã»ããŒã¹ã®ç©è³ªã確èªããããšã«ãããè «çã®çž®å°ãŸãã¯
é²è¡ã調ã¹ãããšãã§ããããšãããè «çã«å¯Ÿããæ²»çã®å¹æãç¥ãããšãå¯èœã§
ãã
MRI: MRI æ€æ»ïŒïŒç£æ°å ±é³Žç»åæ³ïŒã§ã¯ãç£å Žãšé»æ³¢ãå©çšããŠãäœã®çµç¹ã®äž
é£ã®è©³çŽ°ãªç»åãäœæããŸããMRI ã¯ä»ã®ç»åæ€æ»ãããè»éšçµç¹ãé®®æã«æåºã§
ããŸããåè¢ã®è «çã®ç»åæ€æ»ã«åºãçšããããŠããŸãã
骚ã·ã³ãã°ã©ãã£ãŒïŒ æŸå°ç·æšèç©è³ª*ã䜿ã£ãç»åè£ çœ®ã§ãèè «ã®éªšè»¢ç§»èšºæã«
å©çšãããŠããŸããæŸå°ç·æšèç©è³ªã骚代è¬å€åéšäœã«éç©ããããšã§ã骚転移ã
æ€åºããããšãã§ããŸãã
4. ç ççµç¹åŠæ€æ»ãç ççµç¹åŠæ€æ»*ã¯ãçæ€ãŸãã¯æè¡ã«ãã£ãŠå šè «çãé€å»ããåŸã®çµ
ç¹åçã䜿ã£ãŠè¡ãããŸããè «çã®çµç¹ç çåŠç*è©äŸ¡ã«ãã£ãŠã®ã¿ãè «çãè»éšèè «ã§
ãããããŸããã©ã®ã¿ã€ãã§ããããç¥ãããšãã§ããŸãããªããç现èã®æ»ææ§ã®ã¹
ã³ã¢ã§ãããæªæ§åºŠïŒã°ã¬ãŒãïŒ*ããäºæž¬ããŸãããã°ã¬ãŒãã«ã€ããŠã¯ãåŸã»ã©è©³ã
ã説æããŸãã
çæ€*ãšã¯ãè «çã®ãµã³ãã«ãæ¡åãããããé¡åŸ®é¡äžã§èª¿
ã¹ãŠãç现èãæ¢ãããšã§ããçš®é¡ãšããŠã¯ãã³ã¢ãŒéç
æ€ãåé€çæ€ãåéçæ€ããããŸãã
ïŒã³ã¢ãŒïŒéçæ€ïŒå±æ麻é *ã§ãç©¿åºéšã麻çºãããŠã
éã䜿çšããŠæ°åã®ãµã³ãã«ãæ¡åããŸããè¶ é³æ³¢è£
眮*ãCT ã¹ãã£ã³ã«ããéãã¬ã€ãããŠãæ¡åå Žæã®
確èªãã§ããããšãããçã£ããšããããçµç¹ãæ¡å
ããããšãã§ããŸãã
åéïŒåé€çæ€ïŒéº»é äž*ã§è¡ãããè «çå¡ã®äžéšïŒåéïŒããŸãã¯ãè «çå šäœã
æ¡åïŒåé€ïŒããçæ€æ¹æ³ã§ããè¡šåšæ§ã®å°ç å€ïŒ5 ãæªæºã®è¡šåšæ§ïŒã§ããè¡ã
ããŸãã
éåµçæ€ïŒå€ç§çšã®éå ·ã䜿çšãã察象é åãéããå¡ãŸãè «çå šäœããçµç¹ãµã³
ãã«ãæ¡åããŸããè «çã®äœçœ®ãšæ·±ãã«å¿ããŠãå±æ麻é ãŸãã¯å šèº«éº»é äžã§è¡ã
ãŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 11
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æé©ãªæ²»çãåããã«ã¯äœãéèŠãïŒ
å»åž«ã¯ãæ£è ããã«ãšã£ãŠæè¯ã®æ²»çèšç»ãèŠæ¥µããããã«ãæ£è ãããš
è «çã®äž¡æ¹ã«é¢é£ããå€ãã®æ å ±ãåŸãŠæ€èšããå¿ èŠããããŸãã
æ£è ããã«é¢é£ããæ å ± å šèº«ç¶æ ãå¥åº·ç¶æ
æ¢åŸæŽãæè¬ç¶æ³
è¡çžè ã®ãã眹æ£æŽ
女æ§ã§ã¯ãéçµ*æ å ±ãå¿ èŠãªãã°ãæ¡è¡ã§ããã«ã¢ã³ã¬ãã«ã枬
å®ããããšãå¿ èŠã«ãªããŸãã
å»åž«ã«ããèšåºèšºå¯æ å ±
è¡æ¶²æ€æ»ïŒçœè¡çãèµ€è¡çãè¡å°æ¿ãå¿èãèèãè èã®èåšç°åžžãé€å€ãããã
ã«è¡ããŸãã
è «çã«é¢ããæ å ± çæ€*ã®çµæ
çæ€*ã§åŸãè «çãµã³ãã«ã¯æ€æ»å®€ã§æ€æ»ãããŸããããããç ç
çµç¹åŠãšãããŸãã2 åç®ã®ç ççµç¹åŠçæ€æ»*ã¯ãå€ç§çé€å»åŸ
ã®å šè «çã®æ€æ»ãšããŠè¡ãããŸããçæ€*ã®çµæãããè «çã«é¢ã
ã詳现æ å ±ã確èªããããšã¯ãšãŠãéèŠã§ã以äžãå«ãŸããŸãïŒ
- çµç¹åïŒè»éšçµç¹èè «ã«ã¯ãæ°åçš®é¡ã®ç°ãªãçµç¹åŠçäºåã
å«ãŸããŠããŸããçæ€*ãè¡ããäž»èŠãªæœèšã®èè «å°éã®ç ç
å»ã®èšºæãåããããšã匷ãããããããŸããæ人ã®ä»£è¡šçãª
èè «ã¯ä»¥äžãšãªããŸãïŒ
o æªååïŒãŸãã¯æªåé¡ïŒå€åœ¢æ§è»éšèè «*ã¯ãçšã§ã¯ãããŸãããæ人ã§
æãå€ãèè «*ã§ããå šèº«ã«çºçããå¯èœæ§ããããŸãããæãäžè¬çã«
ã¯äžè¢ãç¹ã«å€§è ¿éšã«çºçããŸãã
o èèªèè «*ã¯ãæ·±éšèèªçµç¹ããçºçããŸããå šèº«ã«çºçããå¯èœæ§ãã
ããŸãããåæ°ä»¥äžãå€§è ¿éšãè ¹éšã« 3 åã® 1 ãšãªããŸãã
o å¹³æ»çèè «*ã¯ãå¹³æ»çãšããçèçµç¹ã®äžçš®ã®çŽ°èããçºçããŸããå¹³
æ»çã¯ãå¿èãèã®ãããªåšå®ã®å£ã ãã§ãªããè¡ç®¡ã®å£ã«ãããããšã
ããäœã®ã©ãã«ã§ãçºçããå¯èœæ§ããããŸãããæãäžè¬çãªå Žæã¯ã
åå®®ãåè¢ãèã§ãã
o æ»èèè «*ã¯ãéåžžãäžè¢ãäžè¢ãé žéšã®å€§é¢ç¯ã®è¿ãã«çºçããŸãã
o æªæ§æ«æ¢¢ç¥çµéè «çïŒMPNSTïŒ*ã¯ãç¥çµãåãå²ãçµåçµç¹ããçºç
ããç¥çµç·ç¶èè «ãæªæ§ç¥çµéè «*ãšåŒã°ããããšããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 12
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
o è¡ç®¡èè «*ã¯ãè¡ç®¡ã®å å±€ã®æ§é ã«çºçããããšãããå šèº«ã«èµ·ããåŸãŸ
ããäžè¬çã«ã¯ãç®èãä¹³æ¿ãèèãèŸèãæ·±éšçµç¹ã«çºçããŸãã
o å€çºæ§ç·ç¶æ§è «çïŒSFTïŒ*ã¯ãäž»ã«èžè*ã«çºçããŸãã
o éèµ·æ§ç®èç·ç¶èè «ïŒDFSPïŒ*ã¯ãçç®äžæ·±éšçµç¹ã«çºçããäœå¹¹ã«å€
ãçºçããŸãããäžè¢ãäžè¢ãé é žéšã«ãããèŠãããŸãã
o ç·ç¶ç°åœ¢ææ§å°å圢现èè «çïŒDSRCTïŒ*ã¯ææ¥æããè¥å¹Žæ人ã«çºç
ããäžè¬çã«ã¯æ¥éãªé²è¡ãããããŸããèšåºçç¶ãšããŠã¯ãæ§ã ãªè ¹éš
çŸæ£ãèµ·ãããŸãã
o 暪çŽçèè «*ã¯ãéæéåãè¡ãéªšæ Œçãäœã现èããçºçããŸãããã
ãã暪çŽçèè «*ã¯ãéªšæ Œçãæ¬ æããŠããåšå®ã§ãã£ãŠããäœã®ã»ãŒã©
ãã§ãçèãäœã现èããçºçãåŸãŸãã暪çŽçèè «*ã®å¥œçºéšäœã¯é é ž
éšãèè±ãè£ãäžè¢ãäžè¢ãäœå¹¹ãªã©ã§ããããçšã«ãåç«è ºãäžè³ãè
管ã«ã§ããããšããããŸãã
ãã¹ã¢ã€ãè «çïŒæ·±éšãŸãã¯äŸµè¥²æ§ç·ç¶è «çãšãåŒã°ããïŒã¯ãæ£åŒã«ã¯èè «ãšãããŠããªãçšãªè «çã§ããããã¯ãèºãèèãè¡ç®¡ãå¿èãè èãç®èãè žãªã©ã®åšå®ãæ¯æãŸãã¯ä¿è·ãããäœå šäœã«ãã现èã§ããç·ç¶èœçŽ°èããçããã®ã§ãäžè¬çã«ã¯ãè»éšèè «ãšäžç·ã«åé¡ãããŠããŸãããã¹ã¢ã€ãè «çã¯å®è³ªçã«ã¯äœã®ã©ãã«ãçããå¯èœæ§ããããŸãããã¹ã¢ã€ãè «çã®æ²»çäœç³»ãããã®æåŒãã§ã¯èª¬æããŠããŸãã
- æªæ§åºŠïŒã°ã¬ãŒãïŒïŒè «çã®æªæ§åºŠã¯ãç çåŠè *ã«ãã£ãŠé¡åŸ®é¡äžã§åæãã
ãè «çããã©ã®ããã«âæ»æçãâã«ãã£ãŠãããããŸããè»éšèè «ã§ã¯ãè «ç
ãã©ã®çšåºŠå¥åžžçµç¹ã«é¡äŒŒããŠãããïŒåå床ïŒãåè£ããŠãã现èã®æ°ïŒæ糞
åè£æ°*ïŒãè «çã®äžã«ã©ã®çšåºŠå£æ»çµç¹ãå«ããïŒå£æ»*ïŒããã£ãŠå€å®ããŸ
ããFNCLCC åé¡ã¯ãåå床ãå£æ»*ãæ糞åè£é床*ã«åºã¥ãã3 段éã§æªæ§
床ãè©äŸ¡ããŸãã3 ã€ã®ç¹åŸŽãããè «çã¯ãã°ã¬ãŒã 1ïŒäœæªæ§åºŠïŒãã°ã¬ãŒã
2ïŒäžéæªæ§åºŠïŒããã³ã°ã¬ãŒã 3ïŒé«æªæ§åºŠïŒã«åé¡ãããŸããæªæ§åºŠãäœã
ã»ã©äºåŸ*ã¯è¯å¥œã§ãã
- ååãããã¡ã€ãªã³ã°ïŒè «çã®ç¹åŸŽã«é¢ããè¿œå æ å ±ãå¿ èŠã«ãªãå ŽåããããŸ
ããè¿œå æ å ±ã¯ã现èã®æ§é ïŒæè²äœãéºäŒåãªã©ïŒãååïŒã¿ã³ãã¯è³ªãªã©ïŒ
ã®æ€æ»ã«ãã£ãŠåŸãããšãã§ããŸãããããã®åæã¯ãè»éšèè «ã®çµç¹åŠçäºå
ã確èªã»ç¢ºå®ããçŸæ£ã®äºåŸ*ãããã«ã¯ãæ²»çãç¹ã«æšççæ³*ã®äœ¿çšã決å®ã
ãéã«åœ¹ã«ç«ã¡ãŸããæšççæ³ã¯ã现èã®ç¹ç°çãªã¿ã³ãã¯è³ªãŸãã¯æ§é ã«çµå
ããããšã«ããããã®æ©èœãé»å®³ããããšã«ããå¹æãåŸãããçæ³ã§ãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 13
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç æïŒã¹ããŒãžã³ã°ïŒ å»åž«ã¯ãæ£è ããã®äºåŸ*ãäºæž¬ããããã«ãç æãšããã®è»¢ç§»ã®æç¡ã®èšºæãè¡ã
ãŸããè»éšèè «ã®ç æåé¡ã«æãåºã䜿çšããŠããã®ããTNM åé¡ã§ããT å å
ã¯ãè «çã®å€§ãããšè¿åçµç¹ãžã®æ·±é床ãN å åã¯ããªã³ãç¯*転移ã®æç¡ãM å å
ã¯ãé é転移ã®æç¡ã§ãããããå åãçµã¿åãããŠç æã決ãããšãæ£è ããã®
äºåŸãäºæž¬ããããšãã§ããŸããè»éšèè «ã§ã¯ãç çæªæ§åºŠã®åœ±é¿ã匷ãã®ã§ãæª
æ§åºŠïŒGïŒå åãå ããŠç æåé¡ã䜿ããŸããã¹ããŒãžïŒç æïŒåé¡ã¯ãæ²»çæ¹æ³ã®
æ£ç¢ºãªæ±ºå®ãè¡ãããã®åºç€çãªèãæ¹ã«ãªããŸããç æ°ïŒã¹ããŒãžïŒãäœãã»
ã©ãäºåŸ*ã¯è¯å¥œã§ãã
äžã®è¡šã¯ãè»éšèè «ã®ã¹ããŒãžåé¡ã§ããå®çŸ©ã¯ããå°éçã§ãã®ã§ãæ åœã®å»åž«ã«çŽ°ããª
説æãåããªãããå€æããŠäžããã
ã¹ããŒãž å®çŸ©
Stage IA è «çã - ã°ã¬ãŒã 1 ã«åé¡ïŒ - çŽåŸ 5ïœïœæªæºïŒ - ãªã³ãç¯*ãŸãã¯äœã®ä»ã®éšäœãžã®è»¢ç§»ãªãã
Stage IB è «çã - ã°ã¬ãŒã 1 ã«åé¡ïŒ - çŽåŸ 5ïœïœä»¥äžïŒ - ãªã³ãç¯*ãŸãã¯äœã®ä»ã®éšäœãžã®è»¢ç§»ãªãã
Stage IIA è «çã - ã°ã¬ãŒã 2 ãŸã㯠3 ã«åé¡ïŒ - çŽåŸ 5 cm æªæºïŒ - ãªã³ãç¯*ãŸãã¯äœã®ä»ã®éšäœè»¢ç§»ãªãã
Stage IIB è «çã - ã°ã¬ãŒã 2 ã«åé¡ïŒ - çŽåŸ 5 cm 以äžïŒ - ãªã³ãç¯*ãŸãã¯äœã®ä»ã®éšäœãžã®è»¢ç§»ãªãã
Stage III è «çã - ã°ã¬ãŒã 3 ã«åé¡ãããçŽåŸ 5 cm 以äžããªã³ãç¯*ãŸãã¯äœã®ä»
ã®éšäœãžã®è»¢ç§»ãªãïŒ - ãŸãã¯ããã®å€§ãããã°ã¬ãŒãã«ããããããªã³ãç¯*転移ããã
Stage IV è «çã®å€§ãããã°ã¬ãŒãã«ãããããäœã®ä»ã®éšäœãžã®è»¢ç§»ïŒé é転移*ïŒããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 14
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çã®éžæè¢ãšããŠäœãããã®ïŒ
æ²»çèšç»ã«ã¯ããã®ç æ°ã«é¢ããé«ãã¬ãã«ã®çµéšãæã€å»çå°é家ã«ã
ãåŠéçããŒã ãé¢ãããŸããããã¯äžè¬ã«ãéåŠç*ãªãããªã³ãè «ç
ããŒãã¬ãã¥ãŒãªã©ãšåŒã°ããä»åéã«ãããå°é家ãã¡ã®éãŸãã®ããš
ãæå³ãããã®äŒè°ã§ã¯ãéèŠãªæ å ±ãããšã«æ²»çèšç»ãããŠãŸãã
æ²»çã¯éåžžã以äžã®ãã®ã䜵çšããŠè¡ãããŸãïŒ
æè¡ãŸãã¯æŸå°ç·æ²»ç*ãšãã£ãå±æçãªæ²»çã
ååŠçæ³ãªã©å šèº«ã®ãã现èã«äœçšããå šèº«çæ³*ã
æ²»çã®éžæã¯ãèè «*ã®ã¹ããŒãžãè «çã®ç¹åŸŽãæ£è ããã®ãªã¹ã¯ãèæ ®
ããããã§æ±ºå®ãããŸãã
ããããã®æ²»çã«ã¯ãå©çããªã¹ã¯ãçŠå¿*ããããŸããæ£è ããã¯ãåæ²»çããäºæž¬ãã
ãå©çãšãªã¹ã¯ã«ã€ããŠãå»åž«ã«èããŠãã ãããããã€ãã®æ²»çæ¹æ³ã®å®æœã®å¯èœæ§ãæ²»
çã®éžæãèããå Žåãå©çãšãªã¹ã¯ã®ãã©ã³ã¹ã«åºã¥ããŠå€æããå¿ èŠããããŸãã
éå±æ§çŸæ£ã®æ²»çèšç» è»éšèè «ãããŸã åçºéšäœã«éå±ãããè¿ãã®çµç¹ãäœã®ä»ã®éšäœã«ãŸã§åºãã£ãŠããªã段éã«ãã£ãŠã¯ãæ²»çã®äž»ããç®æšã¯ãæè¡ã«ãã£ãŠå¯èœãªéãå šè «çãé€å»ããããšã§ããæŸå°ç·æ²»ç*ãšååŠçæ³*ã¯ãæ ¹æ²»æ§ãé«ããåçºã®ãªã¹ã¯ã軜æžããããã«å®æœå¯èœã§ãã
転移ã®ãªãè»éšèè «ã®æ²»çã¯ãç æ°ã«åãããå±æéšäœã ããæ²»çããæ¹æ³ãéžæè¢ãšãªã
ãŸãã
æè¡
転移ã®ãªãèè «ã«å¯ŸããŠã¯æè¡ãæšæºæ²»çã§ããè»éšèè «ã¯çšãªçŸæ£
ã®ãããèè «æè¡ã«çç·Žããå»åž«ãæè¡ãè¡ãå¿ èŠããããŸããè «ç
åšèŸºã®åŸ®å°æµžæœ€ãå®å šã«åé€ïŒé¡åŸ®é¡çæ®åé°æ§*ãé°æ§åé€çžïŒã
å®æœããŠãåçº*ãã«ããæè¡ãããªããã°ãªããŸããã
å€ç§çåé€çµæã瀺ãè©äŸ¡æ¹æ³ïŒ
ãR0ãåé€ãšã¯ãç çå»*ãé¡åŸ®é¡ã§è¡ã£ãåé€çžã®åæã
ãããã¹ãŠã®è «çãå®å šã«é€å»ã§ããŠããããšãæå³ããŸ
ãïŒ
ãR1ãåé€ã¯ãé¡åŸ®é¡ã§èŠããšãã«åé€çžã«è «ç现èãååšããããšãæå³ããŸ
ãïŒ
ãR2ãã¯ãèçŒçã«è «çå¡ã®æ®åãèªããããããšãæå³ããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 15
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
å°ããªèè «*ã¯ãæè¡åç¬ã§ååã«åé€ã§ããŸããR1ãR2 åé€ã§ã¯ãåé€çžã®æ®åè «çã
æ²æ» ããããã«è¿œå åé€ãå¿ èŠãªå ŽåããããŸãããã®ä»ã®æ²»çãªãã·ã§ã³ãšããŠãè «ç现
èã®æ®ã£ãåé€çžã«æŸå°ç·æ²»ç*ãååŠçæ³*ãå®æœããæ¹æ³ããããŸãã
æŸå°ç·æ²»ç
5cm ãè¶ ããé«æªæ§åºŠã®æ·±éšçºçã®è «çã¯ãæè¡ãšæŸå°ç·çæ³ã®
çµã¿åããã§æ²»çãããããšãäžè¬çã§ããå®å šé€å»ãç®çã«è «
çã®ãµã€ãºãå°ããããããæè¡åã«æŸå°ç·çæ³ãè¡ãïŒè¡åç §
å°ïŒããŸãã¯ãæè¡åŸã«æ®ã£ãæªæ§çŽ°èãæ»æ» ãããããã«ç §å°
ïŒè¡åŸç §å°ïŒããæ¹æ³ããããŸããæ端éœæ§ã®å Žåã«ã¯ãåæè¡
ãèæ ®ãããããšããããŸãã
ååŠçæ³
転移ã®ãªãèè «ã®æ£è ããã«ååŠçæ³*ãè¡ãããšãæå¹ãã©ããã¯ãäžèŽããæèŠããã
ãŸãããç¹å¥ãªç¶æ³ã®çäŸã§ãååŠçæ³*ãåç¬ããŸãã¯æŸå°ç·æ²»ç*ãšäœµçšããŠãæè¡åãŸ
ãã¯æè¡åŸã«å®æœããŸããç¹ã«ä»¥äžã® 2 ã€ã®ã±ãŒã¹ãèããããŸãïŒ
åçºãªã¹ã¯ãé«ããšèããããã±ãŒã¹ïŒé«æªæ§åºŠãæ·±éšçºçã5cm 以äžïŒããã®å Ž
åã®ç®æšã¯ãå±æåçº*ãªã¹ã¯ãšé éåçº*ãªã¹ã¯ãæžããããšã§ããããããçäŸ
ã§ã¯ãå±ææž©ç±çæ³äœµçšååŠçæ³*ããå±æåçºãªãã«çåçãé«ããããšãããã£
ãŠããŸããå±ææž©ç±çæ³ã¯ãæ²»çããå Žæã®åšãã«æ©æ¢°ãé 眮ããçŽ 42âã®æž©åºŠã§
60 åéå æž©ããŸããç±ã«ããè «ç现èãçŽæ¥æ®ºããããããååŠçæ³è¬ã®å¹æãé«
ããè «çã«å¯ŸããŠã®å ç«åå¿ãé«ãŸããŸãã
è «çåé€ãäžå®å šã§ãæ®åè «çãèµ·ãã£ãã±ãŒã¹ïŒåé€çžè©äŸ¡éœæ§*ïŒãè «çã®ãµã€
ãºã倧ããã£ããã倧è¡ç®¡ãç¥çµãªã©ã«æ¥ããŠããŠãå€ç§çé€å»ã®ãªã¹ã¯ãé«ãã
è «çãå®å šã«é€å»ããããšãã§ãããã«ãªãå Žåããæ£è ããã®å¥åº·ç¶æ ã«ããæ
è¡ã®ãªã¹ã¯ãé«ããªãã±ãŒã¹ã
ä»æ¥ãåè¢çºçã®èè «*ã§ãåæãå¿ èŠãšããããšã¯ãŸãã«ãªããŸããããã®çç±ãšããŠçŸ
åšã¯è «çãšåšèŸºã®çµç¹ã®äžéšã®ã¿ãåé€ããæ£è¢æž©åæè¡*ãã»ãšãã©ã®å Žåã§å¯èœãšãªã£
ãŠããããšãšã æŸå°ç·çæ³*ãååŠçæ³*ãªã©ã®ä»ã®æ²»çæ³ã䜵çšãããããã§ãã
ããéãããå Žåã§ãããåé¢åŒæž©ç±æ£è¢çæµ*ãšããæ¹æ³ãææ¡ããããšããããŸããã
ãã¯ãç现èã«å¯ŸãååŠçæ³*ã®å¹æãé«ããããããããããçŽ 41âã®æž©åºŠã«ãããã
ãããé«çšéã®ååŠçæ³è¬*ã眹æ£ããè ãèã«æ³šå ¥ããŠè¡ãæè¡ãã¯ããã¯ã§ãããã®æ
æ³ã¯ãæè¡ã«ãã£ãŠåè¢ã«æµå ¥ããè¡æ¶²éãšæµåºããè¡æ¶²éã«äžæçãªæ Œå·®ãã€ããå¿ èŠã
ãããŸããããã«ãã£ãŠåè¢ã§ã¯é«æ¿åºŠã§ã®æããå€æ²»çãè¡ãããã€äœã®ä»ã®éšåãžã®æ¡
æ£ãéåžžã«å°ãªãæžã¿ãŸãããã®æ²»çã¢ãã«ã¯è€éãªã®ã§ããã®æè¡ã«ç¿çããæœèšã«éå®
ãããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 16
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
é²è¡çäŸã§ã®æ²»çãã©ã³ è»éšèè «ããçºçããéšäœããé¢ããéšäœã«ãŸã§åºãã£ãç¶æ³ãé²è¡æãšãããŸããããã転移æãšããããŸãããã®ç æ°ã®ç¶æ ã§ã®æ²»çç®æšã¯ãè «çã®é²è¡ãæããç æ°ã«ããçç¶ã軜æžããããšã§ãæ£è ããã®ããè¯ã QOLïŒç掻ã®è³ªïŒãåŸãããšã§ãã
é²è¡æã®ããæ£è ããã¯ãæ£è ããã«ããç¶æ ãæ§ã ãªã®ã§ãæ£è ããããšã«æ²»çæ¹éãè
ããå¿ èŠããããŸãããã®ãããæè¯ã®æ²»çæ¹é決å®ã«ã¯ãå€è·çš®ããŒã ã§ã®æ²»çéžæè¢ã®
泚ææ·±ãæ€èšãæ¬ ãããŸããã
転移æ§ç å€ã§ãã£ãŠãçç¶ç·©åãåŸãããã«å€ç§åé€ãèæ ®ããããšããããããç¹å®ã®æ¡
件ã§ã¯ãæ ¹æ²»ãç®æããæ²»çãšããŠå€ç§åé€ãæ€èšããŸããå ·äœçã«ã¯ãèºä»¥å€ã®è»¢ç§»ã䌎
ããªãå°ãªãæ°ã®èºè»¢ç§»*ã®çäŸã§ãç å€ã®é²è¡ããã£ããé²ãå Žåãªã©ã§ãã
æŸå°ç·æ²»ç*ãçç¶ç·©åããç¹ã«ã骚転移ãªã©é é転移巣ã®ã³ã³ãããŒã«ã®ããã«çšããã
ãŸãã
ããããªãããé²è¡æã®è»éšèè «ã«å¯Ÿããäž»ãªæ²»çæ³ã¯ãååŠçæ³è¬*ãååæšçæ²»çè¬*ã«
ããå šèº«è¬ç©çæ³*ã«ãªããŸããæ²»çè¬ãç°ãªãã°ãããããç°ãªã£ãåãæ¹ãããŸããã
ããã®å¢æ®ãåè£ããã现èã®ä¿®åŸ©éçšã«äœçšããããšã§ãã®ããæ²»çå¹æãçºæ®ãããšã
ãç¹ã§ã¯å ±éããŠããŸãã
ååŠçæ³
ååŠçæ³ã¯ãé²è¡æã®è»éšèè «ã«ããã䞻軞ã®æ²»çã§ããååŠçæ³è¬ã¯è¡æµã«ä¹ããšãæçµ
çã«å šèº«ã«ãŸãã£ãŠãã现èã«ãå°éããŸããè»éšèè «ã«æãçšããããŠããæããå€ã¯ã
ããœã«ãã·ã³*ããã®ä»ã¢ã³ã¹ã©ãµã€ã¯ãªã³*ç³»æããå€ãã€ãã¹ãã¡ãã*ããã©ãã¯ããž
ã³*ãã²ã ã·ã¿ãã³*ããã»ã¿ãã»ã«*ããã¯ãªã¿ãã»ã«*ãªã©ããããŸãã
ååŠçæ³è¬ã¯åç¬ãŸãã¯äœµçšã§çšããããå€æ¥*ãŸãã¯æ°æ¥éã®å ¥é¢*ã§æäžãããŸããååŠ
çæ³*ã¯ã決ããããæ¥æ°ã§ 1 ãµã€ã¯ã«ãšãããŠããã決ãããããµã€ã¯ã«ã§æäžããŸãã
ãã®æäžãµã€ã¯ã«æ°ã¯ãè»éšèè «ã®çš®é¡ãçºçéšäœã倧ãããå¹æããããã©ããã§æ±ºãã
ããŸãã
é²è¡æã®æ£è ããã®ååŠçæ³ã¯ããããœã«ãã·ã³*ããšãã«ãã·ã³ïŒããããã¢ã³ã¹ã©ãµã€
ã¯ãªã³*ç³»æããå€ãšåŒã°ããŸãïŒãåºæ¬ãšããæ²»çãæšå¥šãããŸããè¡ç®¡èè «*ã®æ£è ãã
ã§ã¯ããããœã«ãã·ã³*ã®ä»£ããã«ããã¯ãªã¿ãã»ã«*ïŒãŸãã¯ãã»ã¿ãã»ã«*ïŒãææ¡ãã
ãå ŽåããããŸãã
ãããœã«ãã·ã³*ããšãã«ãã·ã³*ã«å¥ã®ååŠçæ³è¬ã䜵çšããããš
ã§ãè «çã®çž®å°ãããåŸããããå¯èœæ§ããããŸããååŠçæ³ã«ã¯æ
åæ§ããã£ãŠãç¹ã«äœµçšçæ³ã§ããçž®å°ãåŸãããããšãç¥ãããŠã
ãçµç¹åã®è»éšèè «ã«ã䜵çšçæ³ãéžæãããããšãå€ãã§ãããã
ãœã«ãã·ã³*ããšãã«ãã·ã³*ã«å¯Ÿãã䜵çšè¬ãšããŠã¯ãã€ãã¹ãã¡ã
ã*ãæãå€ãéžã°ããŠããŸããããããå¹³æ»çèè «*ãå€çºæ§ç·ç¶æ§
è «ç*ãªã©ã§ã¯ããããœã«ãã·ã³*ãžã®äœµçšè¬ãšããŠãã«ã«ããžã³*ã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 17
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ãã奜ãŸããããšããããŸãã
ãããååã®ååŠçæ³*ïŒäžæ¬¡çæ³ïŒã§å¹æããªãã£ãå Žåã«ã¯ãæå¹æ§ã®ãšããã³ã¹ãé
å®çã§ãã£ãå Žåã«ããå¥ã®ååŠçæ³*ïŒäºæ¬¡çæ³ïŒãææ¡ããããããããŸãããæ²»çè¬
ã®éžæã¯ãäž»ã«ãäžæ¬¡æ²»çè¬ã§äœ¿çšããè¬å€ãäœããšããããšããçµç¹åã«ãã£ãŠæ±ºããã
ãŸããäºæ¬¡æ²»ç以éã®éžæè¢ãšããŠã¯ãã€ãã¹ãã¡ãã *ããã©ãã¯ããžã³*ãã²ã ã·ã¿ã
ã³*ããã»ã¿ãã»ã«*ããã¯ãªã¿ãã»ã«*ãªã©ãèããããŸãã
ååæšçæ²»çïŒè¬ïŒ
ååæšçæ²»çããè»éšèè «ã§è¡ãããŸãããããã£ãæ²»çã¯ãè «çã®å¢æ®ãé²è¡ã«é¢äžãã
ç¹å®ã®ã¿ã³ãã¯è³ªã现èå æ§é ç©ã«äœçšããŠå¹æãçºæ®ããŸããå¯äœçšã¯ããããŸã§çšãã
ããŠããäŒçµ±çãªååŠçæ³*ã®å¯äœçšãšã¯ç°ãªããè¬ç©ãæ£è ããã®äœã«ã©ã®ããã«åœ±é¿ã
ããã«ãã£ãŠéã£ãŠããŸãã欧å·ã§è»éšèè «ã«æ¿èªãããŠããååæšçæ²»çè¬ã«ã¯ãäžèšã®
ãã®ããããŸãïŒ
- ããŸãããïŒèèªèè «*以å€ã®è»éšèè «ïŒ
- ã€ãããã*ïŒç®èç·ç¶èè «*ã«ãããŠãå šèº«çæ³*ãå¿ èŠãªå ŽåïŒ
ç¹å®ã®çšãªçµç¹åã§ã¯ãäžèšä»¥å€ã®ååæšçæ²»çè¬*ãæå¹ã§ãã£ããšããçäŸå ±åãååš
ããå ŽåããããŸãããããã®ãªãã·ã§ã³ã«ã€ããŠã¯ã䞻治å»ãšããçžè«ããŠãã ããã
æŸå°ç·æ²»ç
æŸå°ç·æ²»ç*ã¯çç¶ç·©åãè «çã«äŒŽãæ害äºè±¡ãäºé²ããããã«çšããããããšããããŸã
ãäŸãã°ã骚転移*çäŸã§ã®çŒçãªã©ãžã®å¯Ÿå¿ãšããŠãæŸå°ç·æ²»çãè¡ãå ŽåããããããŸ
ãã
æè¡
転移巣*ãžã®å€ç§æè¡ã¯ããã®ç å€ã®ååšéšäœãç æ°ã®çµéã«ãã£ãŠã¯èãããããããã
ãŸãããäŸãã°ãååæ²»çããé·ãæéãçµã£ãŠããåºçŸããèºè»¢ç§»ã§ãå€ç§å»ãå®å šãªå
é€ãå¯èœã§ãããšèããå Žåãªã©ããããããŸãã
ãªãèšåºè©Šéšã¯éèŠã? èšåºè©Šéš*ã®ç®çã¯ãããã®æ°ããæ²»çæ³ãèŠã€ããããããæ°ããããæ²»çãæšæºæ²»çã
ããå®å šã§å¹æçãã©ããã調ã¹ãããšã§ããèšåºè©Šéš*ã«åå ããæ£è ããã¯ãæšæºæ²»ç
ãåãããããŸãã¯ãæ°èŠæ²»çãåãããã«æ¯ãåãããããããããŸããããŸããèšåºè©Š
éš*ã®ç®çã«ã¯ãçã®åçºãé»æ¢ããæ°ããæ¹æ³ããã¹ããããããçæ²»çã®å¯äœçšãæžå°
ããããããè «çã®æ©æ蚺æã®å¯èœæ§ãæ¢ããããªã©ãããŸããŸãªãã®ãå«ãŸããŸããèšåº
è©Šéš*ã¯ããã«å¯Ÿããæ°ããç¥èŠãåŸãããçŸåšã®æ²»çãããããããããæ°èŠæ²»çãéçº
ãããããããšã§ãçŸåšãŸãã¯å°æ¥ã®æ£è ããã®åœ¹ã«ç«ã€ãã®ã§ããæ¯éãšããããªããå
å ã§ããèšåºè©Šéšããããã©ããã䞻治å»ã«å°ããŠã¿ãŠãã ããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 18
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç¹æ®ãªè»éšè «çãšãã®èšåºæèŠ éåžžã«çšãªèè «ã®ç®¡çã¯ãä»ãŸã§èª¬æããŠããè»éšèè «ã®äžè¬çãªç®¡çãšã¯ç°ãªããŸãã®
ã§ããã®éãã以äžã«èª¬æããŸãã
åŸè ¹èèè «
è ¹å£ãšè ¹èãšã®éã®ç©ºéã§ããåŸè ¹è*ã«çããèè «ããããŸããè*ãšã¯ãè ¹è ã®å å£ã圢
æããè ¹è å ã®å€§éšåãèŠã£ãŠããéšåã§ããåŸè ¹èèè «*ã¯ãäžè¬çã«ãè ¹éšè «ç€ã®ç¶æ
ã§ååšããçç¶ããªããŸãŸéåžžã«å€§ãããªãå¯èœæ§ããããŸããåŸè ¹èèè «ã®çºèŠã«ã€ãªã
ãæãããããåæçç¶ã¯ãèšæºæãçã¿ãåºè¡ãæ¶å管éå¡*ããŸãã¯ãèã®æµ®è «*ãªã©ã§
ãã
åŸè ¹èèè «*ã®èšºæã§ã¯ãç»å蚺æãè «çã®ãµã³ãã«ãåãçæ€*ãè¡ããŸãããç¹å¥ãªæ³šæ
ãæãå¿ èŠããããŸãã®ã§ãå€åéã®å°é家ã®éãŸã£ãããŒã ã«ãã£ãŠæ€æ»ã®çµæãè°è«ã
ã§ããè»éšèè «ã®æ²»ççµéšãããæœèšã§è¡ãå¿ èŠããããŸãã
æè¡ã¯åŸè ¹èèè «*ã®æšæºçæ²»çæ³ã§ããè ¹éšèåšã®å䜵åé€ãå¿ èŠã§ããããã®éšåã¯è§£
ååŠçã«è€éãªæ§é ãããŠãããããå®å šã«åé€ããããšã¯å°é£ã§ããè¡åã®ååŠçæ³*ã
æŸå°ç·çæ³*ãå±ææž©ç±çæ³ããããã¯ãããã®äœµçšçæ³ã¯ãç¹ã«è «çã®ãµã€ãºãçž®å°ãã
å®å šãªå€ç§çåé€ãå¯èœã«ããããšãæåŸ ã§ããå Žåã«ã¯è¡ãããšãæ€èšãããããšããã
ãŸãã
æšæºæ²»çã§ã¯ãªããã®ã®ååŠçæ³*ãšæŸå°ç·çæ³*ãæè¡åŸã«èæ ®ããããšã¯ã§ããŸãããã»
ãšãã©ã®æ£è ããã«å¹æã¯éå®çãšãããŸãã
åå®®èè « åå®®èè «ã¯ãæªæ§çŽ°èãåå®®ã®çèãŸãã¯åå®®ãæ¯ããŠããä»ã®çµåçµç¹ã«åœ¢æãããè «ç
ã§ããè «çã®çš®é¡ã¯ãçºçå ãšãªã现èã®çš®é¡ã«åºã¥ããŠãå¹³æ»çèè «*ãå èé質èè «*ã
æªååèè «*ã«åé¡ãããŸããçèè «ïŒæªæ§ãã¥ãŒã©ãŒç®¡æ··åè «çãšãåŒã°ããŸãïŒã¯ãçŸ
åšãäžç®çµç¹ã«ç±æ¥ããçãšããŠèããããåå®®å èçãšããŠæ²»çãããŠããŸããäžè¬çãª
çç¶ã¯ã骚ç€å ã®çã¿ãå§è¿«æãçç以å€ãéçµåŸã®åºè¡ã§ãã転移ã®ãªãåå®®èè «ã®æšæº
æ²»çã¯æè¡ã§ãåå®®ãšåå®®é žç®¡ã®é€å»ãå«ã¿ãŸããåµå·£ãšåµç®¡*ã®äž¡æ¹ãåãé€ãããšã§äœ
ããã®å©çããããã©ããã¯ããããã£ãŠããŸããããã®ä»ã®ã¢ãããŒããšããŠã¯ãæŸå°ç·
çæ³*ãååŠçæ³*ããã«ã¢ã³çæ³*ããããã¯æ²»çãããªãæ§å芳å¯ããããŸããæè¯ã®æ²»
çæ¹æ³ã¯ãåå®®èè «ã®çš®é¡ãæªæ§åºŠãªã©ãèæ ®ããŠéžæããŸãã
ãã¹ã¢ã€ãç·ç¶è «ç ãã¹ã¢ã€ãè «çïŒæ·±éšã䟵襲æ§ç·ç¶è «çïŒã¯ãåµå·æ²»çãçåœç¶æã«äžå¯æ¬ ãªéèŠãªèåšã®
æ§é ã«ãããŠå€§ããªåœ¹å²ãæãã现èã®äžçš®ã§ããç·ç¶èœçŽ°è*ããçããŸãããã¹ã¢ã€ã
è «çã¯ãå šèº«ã«çºçããå¯èœæ§ããããŸããè¡šåšæ§ã®ãã¹ã¢ã€ãè «çã¯ãäžè¬ã«ç¡çç¶ãŸã
ã¯ããããªçã¿ã䌎ãè «ç€ã§ãããè ¹éšå ã®ãã¹ã¢ã€ãè «çã¯ãæ¿ããçã¿ãèåšç Žè£ãŸã
ã¯å§è¿«ããããã¯åºè¡ãåŒãèµ·ããããšããããŸãã
ãã¹ã¢ã€ãè «çã¯ãç¡ç*ã»ç¡çç¶ã§ãå¢æ®ãæ¢ãŸãäžæçã«éçž®ãèµ·ããããšãããäžæ¹
ã§ã極ããŠé²è¡æ§ãªããšããããŸãã転移ããããšã¯ãããŸãããããæé·ãé ããã°ãè «
çå ç§å»*ã泚ææ·±ã芳å¯ããå¿ èŠããããŸãã
æé·ãéåžžã«é ãè «çã§ããããšãèæ ®ãããªãã°ã泚ææ·±ãçµé芳å¯ãããããšãæé©ãª
æ²»çãªãã·ã§ã³ãšãªãã§ããããè «çã®é²è¡ãã¿ãããå Žåã«ã¯ãæè¡ãæŸå°ç·çæ³*ãå
åŠçæ³*ããã«ã¢ã³çæ³*ãå®æœããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 19
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ä¹³æ¿èè «
ä¹³æ¿èè «ã¯ãä¹³æ¿å ã®çµåçµç¹*ããçããŸããåçºæ§ãŸãã¯äºæ¬¡æ§è «çã®ãããã§ããã
åŸãŸããåçºè «çã¯æãããªåå ããªãçºçããŸãããäºæ¬¡è «çã¯æŸå°ç·çæ³åŸãå¥ã®æªæ§
è «çã®æ²»çåŸã«ãè ãŸãã¯ä¹³æ¿ã®æ ¢æ§ãªã³ãæµ®è «*ãçµæãšããŠçºçããŸããæãå žåçãª
ä¹³æ¿èè «ã¯ãè¡ç®¡ãŸãã¯ãªã³ã管ã«çºçããè¡ç®¡èè «*ã§ããè¡ç®¡èè «*ã¯ãéåžžãèç¶è «ç
ãçèè «ãªã©ã®ä»ã®ã¿ã€ãã®ä¹³æ¿èè «ãããæªæ§åºŠãé«ããªããŸãã
ä¹³æ¿èè «ã®æ£è ããã¯ãä¹³æ¿èè «ã®çµéšãããæœèšã§æ²»çãè¡ãããšãéèŠã§ããæè¡ã¯ä¹³
æ¿èè «ã«ãšã£ãŠæãéèŠãªæ²»çæ³ã§ããæè¡ã®ã¿ã€ãã«ã¯ãåºç¯å²åé€*ãŸãã¯ä¹³æ¿åé€
ïŒä¹³æ¿å šäœãåãé€ãæè¡ïŒããããŸããåºç¯å²åé€*ã¯ãå°ãããŠäœæªæ§åºŠã®ä¹³æ¿èè «ã®
è «çãäœåãªçµç¹ãé€å»ããŠåçºã®å¯èœæ§ãæžããéã«èæ ®ãããŸããè «çã巚倧ãªå Žåã
ä¹³æ¿å€è»¢ç§»ãããå Žåãæãã¯è»¢ç§»ã®å±éºæ§ãæžããç®çã§æŸå°ç·çæ³ãŸãã¯ååŠçæ³*ã
æšå¥šãããããšããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 20
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çã®å¯äœçšã®å¯èœæ§ãšããŠäœãããã®ïŒ
æè¡ã®ãªã¹ã¯ãšå¯äœçš
æè¡ã®äžè¬çãªã¹ã¯
å°æè¡ãçæ€ã§ã¯å€§ããªæè¡ããããªã¹ã¯ãäœããå¯èœæ§ã®ãããªã¹ã¯ãšããŠã¯çã¿ãçæ€
*éšäœã§ã®ææ*ãå±æ麻é è¬*ãžã®ã¢ã¬ã«ã®ãŒåå¿ãªã©ããããŸãã
å šèº«éº»é *äžã§è¡ãããæè¡æ²»çå šè¬ã«å ±éãããªã¹ã¯ããããŸã
ãæ·±éšéèè¡æ ç*ãå¿èãŸãã¯åŒåžåšæ©èœäžå šãåºè¡ãææããŸ
ãã¯éº»é äžã®è¬å€ãã©ãã«ãªã©ã§ãããå»åž«ã¯ãªã¹ã¯ãæå°éã«
æããããã«é©åãªæªçœ®ãšã£ãŠããŸãã®ã§ããããå±éºãªäºè±¡ã¯
æ» å€ã«èµ·ãããŸãããæè¡åã«å»çããŒã ã¯ãå¯èœæ§ã®ãããªã¹
ã¯ã«ã€ããŠæ確ã§äžå¯§ãªæ å ±ãæ£è ããã«äŒããå¿ èŠããããŸ
ãã
åè¢ã®è «çåé€*
æè¡ã®åŸãæè¡åµããã®æ¶²äœãåãé€ãããã®ãã¬ããŒãžã»ãã¥ãŒãããšãã€ããããŠãã
ãããããŸãããå»æ¶²ãæ¢ãŸããšãã¥ãŒããåãå€ãããŸããæ
è¡åŸããã«çã¿ãã³ã³ãããŒã«ãããããé®çå€ã硬èå€æäžãŸ
ãã¯éèå *æäžããŸãã
å€ç§çåé€ã®æ©èœçµæã¯ã骚ãåšå²ã®è»éšçµç¹ã®é€å»ã®çšåºŠã«å·Š
å³ãããŸããå建ãè¡ã£ãŠãåè¢å šäœãç¶æããããšã¯å¿ ããã
å¯èœã§ã¯ãªããæã«ã¯åè¢ã®äžéšã®åæãå¿ èŠãªå ŽåããããŸ
ãã
人ã«ãã£ãŠã¯ãåæã倱ãããåè¢ã®æèŠãçã¿ãæ
ããããšããããããã¯å¹»è¢çãšããŠç¥ãããŠããŸ
ãããã®ç¹å¥ãªçã¿ã«ã¯ãå»çããŒã ã«ããç©æ¥µçãª
ç·©åçæ²»çãå¿ èŠã§ããæçæ£è¬*ãæãã€è¬*ãšãªã
ãªã€ãã®äœµçšã¯ãç¥çµæå·æ§çŒçã®ç·©åãçã¿ã®ã·ã°
ãã«ãé®æããå¹æããããŸãã
æè¡çŽåŸã«ãªãããªãéå§ããŸãããªãããªã®ç®æšã¯ãå¯èœãªéãæ£è ããã®æ©
èœãšèªç«ãæ倧éã«å埩ãããå¿èº«çã瀟äŒçãªç掻ã®è³ªïŒQOLïŒãåäžãã
ããšã§ããåæãæ¬ æããéšåãè£ãŠããã矩足ã䜿ãããªãããã«ãäœå¹¹ãäž
è¢ãäžè¢ã®æ®åçåãèšç·ŽããããšãçåŠçæ³å£«*ãæå°ããŸãã
è ¹éšå ã®è «çåé€*
è ¹éšã®è»éšèè «ã®æè¡ã¯ãä»ã®èåšãçµç¹ïŒäŸãã°ãè èãèŸèãèµèãè žã®äžéšïŒãäžç·
ã«é€å»ããå ŽåããããŸããè¡åŸã®æ¥åžžç掻ãžã®åœ±é¿ã¯ãåå¥ã«å»åž«ã«çžè«ããŠã¿ãŠãã ã
ãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 21
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æŸå°ç·çæ³ã®ãªã¹ã¯ãšå¯äœçšïŒæ害äºè±¡ïŒ
æŸå°ç·æ²»ç*ã®å¯äœçšã¯çŽæ¥æšçãšãããèåšã ãã§ãªããç §å°ãããé
åã®è¿ãã«ããå¥åº·ãªåšå®ã«ãããŠãèµ·ããåŸãŸããæŸå°ç·çæ³*ãšååŠ
çæ³*ã䜵çšãããšå¯äœçšããã匷ããªãå¯èœæ§ããããŸããæè¡ã«å ã
ãŠæŸå°ç·æ²»ç*ãå®æœãããå Žåã«ã¯ãå€ç§çå䜵çã®ãªã¹ã¯ã¯å¢å ãã
åµå·æ²»çã®åé¡ãåŒãèµ·ããå¯èœæ§ããããŸãããã®æ°å幎ã«æž¡ããæŸå°
ç·æ²»ç*ã®æè¡ãšæ©åšãå€§å¹ ã«æ¹åãããé節ãªå¯äœçšã¯éåžžã«çšã«ãªã
ãŸããã
æŸå°ç·æ²»ç*ã«ããå€ãã®æ害äºè±¡ã¯æ²»ççµäºåŸãæéçµéãšãšãã«æ¬¡ç¬¬
ã«æ¶å€±ããŸããæ£è ããã«ãã£ãŠã¯çšã«æ°é±é以äžç¶ãããšããããŸãã
æŸå°ç·æ²»ç*ããŒã ãæ£è ããããµããŒãããŸãã
å³æã®å¯äœçšïŒæ©ææ害äºè±¡ïŒ
æŸå°ç·æ²»ç*ã¯ãå±æçæ³ãªã®ã§ãå¯äœçšã¯ç §å°éšäœã«éå®ãããŸããé »åºŠã®é«ãæ害äºè±¡
ã以äžã«èšèŒããŸãïŒ
- å€éšæŸå°ç·æ²»ç*ãåããŠãã 3ïœ4 é±éåŸã«ç®èåå¿ïŒçºèµ€ãçã¿ãçã¿ïŒã
èµ·ãããŸããããããã¯æ²»ççµäºåŸ 2ïœ4 é±éã§é®éåãå§ããŸããæ²»çããã
éšåã«ã¯è»œãè²çŽ æ²çãæ®ããŸãã
- é£éã®ççã«èµ·å ããå¥äžé害ã¯ãé žéšãŸãã¯èžéšãžã®æŸå°ç·*ç §å°ã§ãããèµ·
ãããŸãã
- åæ°ãååãäžç¢ïŒæ²»çã«ãã£ãŠã¯æ°åãæªããªãããšããããŸãããããã¯ã
æ²»çé åãèãŸãã¯è žã®è¿ãã«ããå Žåã«ããèµ·ãããŸãã
- è±æ¯ã¯ãé éšç §å°ã§èµ·ãããŸãã
- ç²åŽã»åŠæ æã¯äžè¬çãªå¯äœçšã§ãæ²»ççµäºåŸããã°ããç¶ããŸãã
- åã®çã¿ãå£ã®ç²èã®ççïŒå£è ç²èç*ïŒïŒå£è çã也ç¥ã®ä»ããã®æ²»çäžã«
å°æœ°çãèµ·ããããšããããããã¯ãæ²»çé åãå£è ã®è¿ãã«ããå Žåã«ããèµ·
ãããŸããå£ã®äžã也ç¥ãããªãç¶æ ã«ä¿ã¡ãæ²»çäžã¯æ¯å šäœãæž æœã«ä¿ã€ããš
ã¯éåžžã«éèŠã§ãã
é·æçãªå¯äœçšïŒæ©ææ害äºè±¡ïŒ
æŸå°ç·æ²»ç*åŸã«ãé節ã§é·æçãªå¯äœçšãèµ·ããããšã¯çšã§ããããããªãããé·æçãª
å¯äœçšã¯ãæ£è ããã®ç掻ã®è³ªïŒQOLïŒã«ã倧ããªåœ±é¿ãããããŸããèµ·ããåŸãå¯èœæ§
ã®ããé·æçãªå¯äœçšã¯ä»¥äžãšãªããŸãïŒ
- é·æçãªç®èã®å€åïŒ
- ãªã³ãæµ®è «*ã®çºçïŒãªã³ãç¯*ããã³è¡ç®¡ãæŸå°ç·æ²»çã«ãã£ãŠæå·ããå Žåã«
èµ·ããè «ãïŒïŒ
- è žãèè±ãäžå ·åïŒå€±çŠ*ïŒãäžåŠçããã³æ©æéçµ*ãæŸå°ç·çæ³*åŸã«äžåŠç
ã®ãªã¹ã¯ãããå Žåãæ²»çåã«äž»æ²»å»ã¯æ£è ãããšè©±ãåãããã¹ãŠã®ãªãã·ã§
ã³ã«ã€ããŠææ¡ããŸããç·æ§ã§ã¯ç²Ÿååçµä¿åã女æ§ã§ã¯åµååçµä¿åãããŠã
å°æ¥ã®æ²»çã®æºåãããŸãã
- ç §å°éå ã®ç¥çµã§ãç¥çµé害æ§çŒçãèµ·ããããšããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 22
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æŸå°ç·æ²»ç*åŸãäœå¹Žãçµéãããšç¬¬ 2 ã®æªæ§è «çãçºçãããªã¹ã¯ãå°ãé«ãŸããŸããæŸ
å°ç·æ²»çã®çš®é¡ãæ²»çéã工倫ãããšããªã¹ã¯ãäžããããŸãã®ã§ãæ²»çã¯æ éã«èšç»ãã
ãŸãã
ååŠçæ³ã®ãªã¹ã¯ãå¯äœçšïŒæ害äºè±¡ïŒ
ååãªãµããŒãäœå¶ã§ç®¡çããŠããå Žåã«ãã£ãŠããååŠçæ³*ã®å¯äœçšã¯é »åºŠã®é«ããã®
ã§ããå¯äœçšã¯ãæäžãããè¬å€ã®éãããããã®æ§è³ªã«å·Šå³ãããŸããããæ£è ãããä»
ã®å»åŠçãªåé¡ãæ±ããŠããå Žåã¯ãæ²»çå°å ¥åã®å¯Ÿå¿ãå¿ èŠã§ããããŸãæ²»çè¬ã®é©å¿ã«
ã€ããŠã®æ€èšãå¿ èŠã§ããæ£è ããã¯ãéå»ã®çµéšãæ²»çæŽã«ã€ããŠãå»çããŒã ã«äŒããŠ
ãã ããã
以äžã¯çŸåšãè»éšèè «ã«äœ¿çšãããŠããååŠçæ³è¬ã§çºçããããšãç¥ãããŠãã代衚çå¯
äœçšã§ããå¯äœçšã®æ§è³ªãé »åºŠããã³éç床ã¯ã䜿çšãããæ²»çè¬ã®çµã¿åããã«ãã£ãŠã
å€ãããŸãã
æãäžè¬çãªååŠçæ³*ã§èªããããå¯äœçšïŒæ害äºè±¡ïŒã¯ïŒ
- ææçã®ãªã¹ã¯ïŒååŠçæ³*ã¯ã现èã®æé·ãåçããèœåã劚害ããçœè¡çïŒçœè¡
çã¯ç åäœãšæŠãïŒã®æ°ãæžãããŸããçœè¡ç*ã®æ°ã確èªããããã«ãååŠçæ³*
ãåããåã«è¡æ¶²æ€æ»ãè¡ãããŸãã
- åºè¡ã®ãªã¹ã¯ïŒååŠçæ³*ã¯è¡æ¶²ã®ååºãå©ããè¡å°æ¿*ã®æ°ãæžããããšããããŸ
ãã è¡å°æ¿æ°*ãå°ãªãå Žåã«ã¯ãè¡å°æ¿èŒžè¡ãå¿ èŠã«ãªãããšããããŸãã
- 貧è¡*ïŒååŠçæ³*ã¯èµ€è¡ç*ã®æ°ãæžããããšãããããã®ããæ£è ãããæ¯åãã
æããå ŽåããããŸããèµ€è¡çæ°*ãå°ãªãå Žåã«ã¯ã茞è¡ãå¿ èŠã«ãªãããšããã
ãŸãã
- åãæ°ãšååïŒå¹æçãªå¶åè¬*ã«ãããåãæ°ãååãäºé²ããã軜æžããããšã
ã§ããŸãã
- å£è å ã®çã¿ïŒå£ã®äžãçãã£ãã也ããããæ²»çäžã«å£å çãã§ããããšããã
ãŸããæ°Žåæåãæ¯ç£šããªã©ã§å£è å ã±ã¢ããããšãç²èç*ãæããããšãã§ããŸ
ãã
- è±æ¯ïŒå šãŠã®ååŠçæ³*ãè±æ¯ãèµ·ããããã§ã¯ãããŸãããã髪ãèããªãçšåºŠã
ããæ¯ãå®å šã«æããŠããŸããŸã§ãšå¹ ããããŸããããè±æ¯ãèµ·ããŠããååŠçæ³*
çµäºåŸã3ïœ6 ãæãçµã€ãšã髪ã¯ã»ãŒå ã«æ»ããŸãã
- åŠæ æïŒ äœã®ã ããã¯ãååŠçæ³è¬*ã®ããããæ害äºè±¡ã®äžã€ã§ãã
- åŠããæ§ïŒäžåŠã®ãªã¹ã¯ããããŸãã®ã§ã䞻治å»ããæ²»çåã«ãã¹ãŠã®éžæè¢ãšæ
äŸã§ãããµããŒãã«ã€ããŠã話ãåããæããããšæããŸãã
éèã«ç¹æ»Žããå Žåããã®éšåãå±æåå¿ãèµ·ããããšããããŸããéèããè¬å€ãæŒãã
ãšãæŒããåšèŸºã®çµç¹ãæå·ãåããå¯èœæ§ããããŸãã
ååŠçæ³è¬*ã«ãã£ãŠã¯ãããç¹æ®ãªæ害äºè±¡ãèµ·ãããããããŸãããããªãã®ç æ°ã®æ²»
ççµéäžã«äœ¿çšã§ããå šãŠã®ååŠçæ³è¬*ã䜿ãããããã§ã¯ãããŸãããè»éšèè «ã®çµç¹
åã«ãããŸãã®ã§ãæ害äºè±¡ã®å 容ãã䜿çšããè¬å€ããšã«ç°ãªãéšåããããŸããæ²»çã
ãŒã ããæ£è ããã«ãè¬å€ããšã«æ³å®ãããæ害äºè±¡ã«ã€ããŠæ²»çå°å ¥åã«èª¬æããããšæ
ããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 23
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
- äŸãã°ããããœã«ãã·ã³*ããšãã«ãã·ã³*ãæäžãããšæ°æ¥ã«ããã£ãŠå°¿ãèµ€ããª
ã¬ã³ãžè²ã«å€åããããšããããŸããããã¯è¡å°¿ãšã¯éã£ãŠè¬å€ã®è²ã§ãã®ã§ãå¿
é ããªãã§ãã ããã
- ãããœã«ãã·ã³*ããšãã«ãã·ã³*ã¯å¿çãå·å®³ããæãããããŸãããã®ãããã
ã 2 å€ã䜿ãåã«ã¯ãå¿èã®æ©èœã®è©äŸ¡ãå¿ èŠã§ããå¿èé害ã®å±éºæ§ã¯ãæäžé
ãšæ£è ããã®ç¶æ ã«ãã£ãŠå€åãããšãããŠããŸãããã ããå¿èé害ã¯ãæ£è ã
ãã«ãªã¹ã¯å åããªããŠãèµ·ããå¯èœæ§ã¯ãããŸãããŸãããããã®è¬å€ã«ããã
ç®èãæ¥å ã«éæåå¿ã瀺ãããã«ãªãå¯èœæ§ããéå»ã«æŸå°ç·ãåããéšåãèµ€
ããªãããšããããŸãããããœã«ãã·ã³ããšãã«ãã·ã³ãæäžãããšãæ°æ¥ã«ãã
ã£ãŠå°¿ãèµ€ããªã¬ã³ãžè²ã«å€åããããšããããŸããããã¯è¡æ¶²ã§ã¯ãªãããã ã®
è¬å€ã®è²ã§ãã
- ã€ãã¹ãã¡ãã*ã¯è¡å°¿ãèµ·ãããããèè±ã®çã¿ãèµ·ãããªã©ãè æ³å°¿åšã®åé¡ã
åŒãèµ·ãããããããŸãããäžéšã®äººã§ã¯ãç ããªã£ãããå¹»èŠãèŠãããæ··ä¹±ã
ãïŒããåŠïŒãªã©ãç¥çµæ¯æ§*ïŒäžæ¢ç¥çµç³»ã®åé¡ïŒãèµ·ããå ŽåããããŸãã
- ãã»ã¿ãã»ã«*ã¯ãæµ®è «ãäœæ¶²è²¯çãåŒãèµ·ããå ŽåããããŸããæã«ã¯ãäžæçãª
çªã®è±è²ãçãçºç¹ã䌎ãããšããããŸããç¹ã« 1ïœ2 åç®ã®æäžã§ã¯ãéçã®ã¢
ã¬ã«ã®ãŒåå¿ãèµ·ããããšããããŸãã
- ã²ã ã·ã¿ãã³*ã¯åŒåžå°é£ã®ãããªãèºã®åé¡ãèµ·ããå ŽåããããŸããããã¯æäž
çµäºåŸ 2 é±åŸããããŸã§ã«ãèµ·ããå¯èœæ§ããããŸããã²ã ã·ã¿ãã³*ã¯ãç±ã£ãœã
ãå¯æ°ãé çãšãã£ãã颚éªã®ãšãã®ãããªçç¶ãèµ·ããå ŽåããããŸãã
- ããã¬ã«ãã³*ã¯ãæ«æ¢¢ç¥çµé害ãšãããæã足å ã®ã¡ãã¡ããããããªããŸãã¯ã
ãã³ãã®ãããªéåæãåŒãèµ·ããå ŽåããããŸãã
- ãã³ã¯ãªã¹ãã³*ã¯ã䟿ç§ãè ¹çãæã足å ã®ã¡ãã¡ããããããªããŸãã¯ãã³ãã®
ãããªéåæãåŒãèµ·ããå ŽåããããŸãã
- ãã«ã«ããžã³*ã¯ãèæ©èœé害ãèµ·ããå ŽåããããŸãããŸãããã«ã«ããžã³*ã¯è¡
管çããè¡ç®¡å€ã«è¬å€ãæŒããå Žåã«ã¯ç®èã®ããã©ã®ãããªçç¶ãèµ·ããããã
ããŸãããç®èã®çºèµ€ãçŒç±æãçã¿ãè «ããç¹æ»ŽãæäžãããŠããç®èã®éšåã
ãã®æ¶²æŒããªã©ãèµ·ããå Žåã«ã¯ãæ åœå»ã«ãçžè«ãã ããã
- ã·ã¹ãã©ãã³*ã¯è èã«é害ãèµ·ããå¯èœæ§ããããŸãããã®ãããæ²»çã®åãæ²»ç
ã®æäžã«ãæ¡è¡ã§è æ©èœããã§ãã¯ããŸããè èãä¿è·ããããã«ãã·ã¹ãã©ãã³
æäžã®ååŸã§ãéè*ããæ°Žåç¹æ»Žã®è¿œå ãè¡ãããŸãã
- ã·ã¯ããã¹ãã¡ãã*ã¯èè±ã®é害ãèµ·ãããæå°¿æã«äžå¿«æãåŒãèµ·ããå¯èœæ§ã
ãããŸãããŸããã·ã¯ããã¹ãã¡ããã¯è èãèæ©èœã«ã圱é¿ããŸãããéåžžã¯è»œ
埮ã§æ²»ççµäºåŸã¯æ£åžžåããŸããé«çšéã®æäžã®å Žåã«ã¯ãèºãå¿èã«åœ±é¿ããå Ž
åããããŸããçšã§ã¯ãããŸããã2 次çãåŒãèµ·ããå¯äœçšãããããšãç¥ãã
ãŠããŸãã
- ãã©ãã¯ããžã³ã¯è¡ç®¡å€ã«è¬å€ãæŒããå Žåãç®èãªã©ã®çµç¹é害ãèµ·ããããã
ããŸããããŸããèèãè æ©èœãæªåããããæã«æäžåŸæ°æ¥ã®éãé¢ç¯ãçèç
ãèµ·ããããšããããŸããä»ã®èµ·ããåŸãå¯äœçšãšããŠã¯ãæ·±éšéèã®è¡æ çãã
ããŸãã
çºç¹ãããã¿ãæ¯åããåŒåžèŠãå³ãé¡é¢ãå£åãèãã®ã©è «ããªã©ã®çç¶ãèµ·ãããå Žå
ã«ã¯ãæ åœå»ã«çžè«ããŠãã ããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 24
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æšççæ³åŸ¡ãªã¹ã¯ãšå¯äœçš
ããŸããã*ãã€ãããã*ã¯è»éšèè «ã«æ¿èªãããŠããååæšçæ²»çè¬ã§ãã
ããŸããã*ã®äž»ãªå¯äœçšã¯ãæµ®è «*ïŒäžè¢ãè ãé¡ïŒãåµå·æ²»çé 延ãé«è¡å§ãäžç¢ãåŠæ
æãèæ©èœé害ïŒéåžžã¯æ¡è¡ã§ã®èé µçŽ äžæããå€æããŸãïŒãååºç°åžžïŒåºè¡ãè¡æ ïŒã
æ¯é«ªã®ç°åžžã§ãã
ã€ãããã*ã¯ãããŸããäžç¢ãããã€ããååãçèã®çæ£ãåºè¡ãçŒã®ããã¿ãæµ®è «*ã
ãããŠãã¯çŒã®åšå²ãäžè¢ãæã®è¶³å ãåã®ã¡ãã¡ããããããªããŸãã¯ãã³ãã®ãããªé
åæãèµ·ããããšããããŸããã€ãããã*ã¯ææçãšæŠãçäœå ã®çŽ°èã§ããçœè¡çã®äž
éšã奜äžçæ°ã®æžå°ãèµ·ããããšããããŸãã
äžèšã®ãããªå¯äœçšã¯ããããŠãé©åãªå¯Ÿççæ³ãæäžéã®èª¿ç¯ã§ãããªããŸãã®ã§ãæ£è
ããèªèº«ãæããŠããäžå¿«ãªçç¶ããã¡ããšæ åœå»ã«äŒããããšããšãŠãéèŠã§ãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 25
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ããæ£è æ¯æŽå£äœã¯ã©ã®ããã«åã«ãªã£ãŠãããã®ãïŒ By Markus Wartenberg of the Sarcoma Patients EuroNet Association (www.sarcoma-patients.eu)
蚺æã®æ¥ã«ã蚺å¯å®€ã«ããæ£è ããæ¬äººã«ãšã£ãŠããæ£
è ããã®æãæ¡ããããŠãã家æã®æ¹ã«ãšã£ãŠãããã
ãã¯ãåéã®ããšãæ °ããŠããæ¹ã«ãšã£ãŠããèè «ãšã
ã蚺æã¯ã¯ãããŠã§ãæã£ãŠãã¿ãªãã£ãæãããçµéš
ã§ããçªç¶ãåŠã°ãªããã°ãªããªãããšãç解ãã¹ãã
ãšã察åŠããªããã°ãªããªãããšãå±±ã®ããã«ãããŠåºãŸããããã幞ãã«ããæ£è ããã
家æã¯å€ç¬ã§ã¯ãããŸããããããŸã§äžåºŠããèè «ããšããèšèãèããããšããªããæ§ã
ãªçåããããã©ã®ã¿ã€ãã®èè «ãªã®ããã©ã®ãããªæ²»çã®éžæè¢ãããã®ãã®ãªã©ã®æ£ã
ãæ å ±ãæ¢ããŠãããšãããåãç¶æ³ã®æ¹ãããŸãã
ãšãŒãããã®åœã ã®äžã«ã¯ãèè «ã®æ£è ãããã¡ãéãŸããæ£è æ¯æŽã®ããã®ã°ã«ãŒããç«
ã¡äžããŠãããšããããããŸãããããã®ãã¡ã®å€ãã¯ãæ£è ããèªèº«ãšãã®å®¶æã«ãã£
ãŠãæ£è ããã®ããã«èšç«ãããéå¶å©å£äœã§ãããããã®å£äœã®äœ¿åœã¯ãèè «*ã®å°é
家ãç 究ã«é¢ããç£æ¥çãä¿éºäŒç€Ÿãä»ã®æ£è å£äœãæ²»çãç 究æ¹æ³ãæ¹åããå»çå¶åºŠã«
é¢ãã代衚è ãã¡ããèè «ãæ¶å管éè³ªè «çïŒGIST*ïŒããã¹ã¢ã€ãããããã¯ç¹æ®ãªã¿ã€
ãã®éªšã®è «çã®æ£è ãããã¡ã®ããã®æ²»çãç 究ç°å¢ãåäžãããããã«ãååããŠããã
ãšã§ããæãéèŠãªä»»åã¯ä»¥äžã®ãããªãã®ã§ãïŒ
æ£è ããã®æ å ±ãèœåã®ã¬ãã«ãé«ããããšïŒããããã°æ£è ããèªèº«ãå©ããã
ãšã«ã€ãªãããŸãïŒ
æ°èŠæ²»çãžã®ã¢ã¯ã»ã¹ã確ä¿ããæ²»çã®è³ªãé«ããããš
èè «*ã«ã€ããŠã®ç 究ãæ¯æŽããããš
åœã®ä¿å¥å»çæ¿çã«ãããŠçºèšããããš
äžæ¹ãéåŠçãªèè «*ã»ã³ã¿ãŒã§é©åãªææã«è¡ãããæ²»çã«ãã£ãŠãå€ãã®æ£è ããã®æ²»
çå¹æãäºåŸãèæã«æ¹åãããŠããããšãããããã®ç 究ã瀺ããŠããŸãããã£ãŠ
ESMO ã NCCN ãªã©ã®åœéçãªæ²»çã¬ã€ãã©ã€ã³ããšãŒãããã®èè «æ£è ã®çµç¹ã¯ãèè «
ãåžå°çŸæ£ã§ãããšããããšãèæ ®ããŠãçµéšè±å¯ãªå»åž«ãã»ã³ã¿ãŒã§æ²»çãããã¹ãã ã
ãšäž»åŒµããŠããŸãã
æ®å¿µãªããå€ãã®è»éšèè «ã®æ£è ããã¯ãçµéšè±å¯ãªå»åž«ã«ãã©ãçãåã«å»çä¿å¥ã·ã¹ã
ã ã®äžã§å€ãã®æéãç¡é§ã«ããŠããŸããèè «*ã»ã³ã¿ãŒã®ååšããã£ãšæ©ãç¥ããããŠã
ãã°ããããã¯äž»æ²»å»ããã®ãããªå°é家ã«ã€ããŠèšåããŠããã°ããã£ãšæ©ãæ£è ããã®
ç æ°ã¯èšºæããããã£ãšããæ²»çãåããããã¯ãã§ããããé·ãäºåŸãæåŸ ã§ããæ£è ã
ãããããããããŸããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 26
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ããèè «ãšçãããã蚺æãããããæè¡ãåãããé·æã«ãããæ²»çãéå§ããåã«ãå¥
ã®å»åž«ã«ã»ã«ã³ããªãããªã³ãããããšããã§ããããããã«ãæ£è ãããæåã«åãã蚺
æã«çããæã£ããããã蚺ãŠããã£ãŠãããšæããããªããšæã£ãããããããªãšãã«ã¯
çµéšã®ããèè «ã»ã³ã¿ãŒãªã©ã§å¥éããäžåºŠèšºãŠãããããšãããããŸããã»ã«ã³ããªãã
ãªã³ã¯ã誀蚺ã®å¯èœæ§ãæé€ããæ²»çéžæè¢ã«ã€ããŠç¢ºèªããå¯èœã§ããã°æ°èŠã®ç°ãªãæ²»
çæ¹æ³ãæ瀺ããŠãããŸããèè «æ£è ã®æ¯æŽã°ã«ãŒãã¯ãåœå ã®èè «ã®å°é家ã®å šäœåãã
ãææ¡ããŠããŸããåœå ã®ã©ãã«èè «ã®å°é家ãããããããç¥ã£ãŠãããæ£è ãããã»ã«
ã³ããªãããªã³ãèŠã€ããã®ãå©ããŠããããšãŠãçšãªã¿ã€ãã®èè «*ã§ããã°ãç¹æ®ãªæ²»
çæ¹æ³ãèšåºè©ŠéšãèŠã€ããã®ãå©ããŠãããŸãã
ããæ£è ãããèªåã®ç¶æ³ã«ã€ããŠãã£ãšæ å ±ã欲ãããšæããšããããã èªãåã誰ãã
å¿ èŠã ãšæããšãã«ã¯ãèè «æ£è ã®æ¯æŽã°ã«ãŒãã«é£çµ¡ãåãããšãéåžžã«ææ矩ã§ãã
ããæ¯æŽã°ã«ãŒããæ åå£äœã®ãªã¹ããå¿ èŠãªå Žåã«ã¯ãSarcoma Patients EuroNet
Associationâs group locator page ã®ããŒãž ( http://www.sarcoma-patients.eu) ã«
ã¢ã¯ã»ã¹ããŠã¿ãŠãã ããã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 27
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çåŸã«ã©ããªããšãèµ·ãåŸããïŒ å»åž«ãšã®ãã©ããŒã¢ãã
æ²»çã®ãŽãŒã«ãäœã§ãããæ²»çåŸã¯æ°å¹Žã«ãããå®æçãªãã©ããŒã¢ã
ããåããŸããåçºã®å ãããªãã確èªããããã®èšºå¯ããå šèº«ç¶æ ã
æ²»çã®å¯äœçšããã§ãã¯ããããã«è¡æ¶²æ€æ»ãè¡ãã®ãéåžžã§ããåçº
å·£ãèè «*ã®ã¿ã€ãã«ãã£ãŠã¯ãç»åæ€æ»ãè¡ãããšããããŸãããã
ããå®æ蚺å¯ã®æ©äŒã¯ãæ°ããæ°ä»ããçç¶ãå€åãäŒãããã質åã
çåã話ããããããéåžžã«å€§åãªæéã§ãã
æåã®ãã¡ã蚺å¯ã¯æ°ãæããšã§ããããåãéããããšã«åçº*ã®å±
éºæ§ã¯äœããªã£ãŠãããŸãã®ã§ãåŸã ã«èšºå¯ééã¯éããŠãããŸããäž
è¬ã«ãé«ãªã¹ã¯ã®è»éšèè «ã¯ååæ²»çããïŒïœïŒå¹Žã®ãã¡ã«åçº*ãã
å¯èœæ§ããããšããããŸããäœãªã¹ã¯ã®å Žåã¯ãã£ãšæéãçµã£ãŠãã
ã®åçº*ãå€ããå¯èœæ§ãäœãã§ãã
æ®æ®µã®æ€æ»ã¯ããšããšã®è «çã®ã°ã¬ãŒãã倧ããããããŠéšäœã«ãã£ãŠç°ãªããŸãããããã
é«ãäžç床æªæ§åºŠã®èè «ã®æ²»çåŸæ€æ»ã¯ãäœæªæ§åºŠã®èè «*ã«æ¯ã¹ãŠãã詳现ãªæ€æ»ãšãªã
ãŸãã
æ¥åžžç掻ã«æ»ã
æ¥åžžç掻ã«åŸ©åž°ããããšã¯ãèè «ã®æ²»çã®äž»ãªç®æšã®äžã€ã§ããããŸããããããäžå®ãå
é¡ãèªå® ãä»äºãåŠæ ¡ã«åŸ©åž°ããããšã«ã€ããŠã®æãããå»åž«ã«è©±ããŠã¿ããšããã§ããã
ãåãã£ãŠã±ã¢ããŒã ãšçžè«ããŠããããšãå¿ããªãã§ãã ãããããããã°å©ããŠããã
ãŸããå æ£è ã®ã°ã«ãŒãããæ£è ã察象ãšããæ å ±ã¡ãã£ã¢ãããæ¯æŽãèŠã€ããããšãã§
ããã§ããããå°é家ã«ããå¿çé¢ã§ã®ã¢ããã€ã¹ã¯ãšãŠã圹ã«ç«ã€ã§ãããã
ããåçºãããã©ãããã®ãïŒ
è»éšèè «ã¯ããšããšè «çããã£ãéšäœã«åçº*ããå¯èœæ§ããããŸãããããå±æåçºãšåŒ
ãã§ããŸããå±æåçºã®ã¿ã®æ£è ããã¯ãããäžåºŠæè¡ã§ã®è «çåé€ãæåŸ ãããããããŸ
ããããè¿œå ã®æ²»çãå¿ èŠãšãªãããšããããŸãã
è»éšèè «ã¯åœåãšç°ãªãèåšãéšäœã«ãåçºãåŸãçŸæ£ã§ãããããé é転移*ãšåŒãã§ã
ãŸããèè «ã®æ£è ããã§ã¯èºã骚ãèèãžã®è»¢ç§»ãèµ·ããããšãå€ãã§ããé é転移ã¯ç¹ã«
åé€ãå¯èœãªãããã®åæã«ã¯çç¶ãããããªãããšãå€ãã®ã§ã䞻治å»ã¯è¡åŸã®ãã©ããŒ
æéäžã«ããããéšäœã«æ³šæãæããŸãããã§ã«å šèº«æ²»ç*ãåããŠããæ£è ããã§ããã°
ãããªãæããå€æ²»çãæšçæ²»çãæ€èšãããŸãã
æŸå°ç·æ²»ç*ã¯çç¶ç·©åãè «çã«ããå䜵çãäºé²ããããã«çšããããã§ããããå€åé
ã«ãŸãããããŒã ãåçºè «çãè©äŸ¡ãããã£ãšãé©åãªæ²»çæ³ã䜵çšçæ³ãéžæããããšã
éèŠã§ãã
è»éšèè «ã®æ²»çã®åœ±é¿ã§ãäºæ¬¡çºãããèµ·ããããšããããŸããäºæ¬¡ãããçãããå Žåã«
ã¯ãå»åž«ã¯ãã®ã¿ã€ããšçšåºŠãåæããããã®è«žæ€æ»ãè¡ãã§ããããæé©ãªæ²»çéžæè¢ã¯
ãããŸã§ã«èè «ã«ã€ããŠè¡ãããæ²»çå 容ãèæ ®ãã€ã€ãå€åéã®ããŒã ã§æ€èšãããå¿ èŠ
ããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 28
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
çšèªã®èª¬æ
CT ã¹ãã£ã³ïŒã³ã³ãã¥ãŒã¿ãŒæå±€æ®åœ±ïŒ
èåšã X ç·ã§ã¹ãã£ã³ããã®çµæãã³ã³ãã¥ãŒã¿ãŒã§åŠçããèåšã®ç»åãæ§æãã X ç·
æ®åœ±ã
X ç·
X ç·ã¯ãç©äœã®å é¢ã®ç»åãæ®åœ±ããéã«çšããããæŸå°ç·ã®äžçš®ãå»çç®çã§ã¯ãX ç·ã¯
äœã®å éšã®ç»åãåŸãããã«ãäžè¬çã«çšããããŠããŸãã
ã¢ã³ãã©ãµã€ã¯ãªã³
å€ãã®ç¯å²ã®ããæ²»çã§ååŠçæ³ãšããŠäœ¿çšãããæçç©è³ªã
ã€ãã©ã¹ãã¡ãã
ä»ã®è¬å€ã«ãã以åã®æ²»çã«åå¿ããªãã£ã粟巣è现èè «çã®æ²»çã«çšããããè¬å€ã§ãå¥
ã®è¬å€ãšäœµçšãããŸããä»ã®çš®é¡ã®çã«å¯Ÿããæ²»çè¬ãšããŠãç 究ãããŠããŸããã€ãã©ã¹
ãã¡ããã¯çŽ°èå ã® DNA ã«çµåããŠãç现èã殺å·ãããã¢ã«ãã«åå€ã®äžçš®ã§ããã代
è¬æ®æè¬ã®äžçš®ã§ããããŸãã
ã€ãããã
ã€ããããã¯ããã·ã³ãããŒãŒé»å®³è¬ã§ããããã·ã³ãããŒãŒãç¹ç°çã«é»å®³ããŸãããã
ã·ã³ãããŒãŒã¯å¢æ®ãããã现èã®è¡šé¢ã«å«ãŸããã€ããããã¯ãããã®å容äœã®åããé»
害ããããšã«ãã£ãŠçŽ°èåè£ãã³ã³ãããŒã«ããŸãã
ãŠã§ã«ããŒçå矀
ææ¥æããã¯ããŸãæ¥éãªèåã«ãã£ãŠç¹åŸŽã¥ããããéºäŒæ§é害ã§ããæ£è ããã¯å¹³åã
ããå°æã§ã髪ã®æ¯ã倱ã£ããçœé«ªã«ãªããåè硬åã骚ãèããªããç³å°¿ç ãèã硬åã
ããªã©å¥åº·äžã®åé¡ãèµ·ãããŸããæ£è ããã¯ãããã®ãªã¹ã¯ãç¹ã«éªšèè «ïŒéªšã®ããã®äž
çš®ïŒã®ãªã¹ã¯ãé«ããªããŸãããŠã§ã«ããŒçå矀ã¯ã现èåè£ã«é¢äžããéºäŒåã®çªç¶å€ç°
ïŒå€åïŒã«ãã£ãŠåŒãèµ·ããããããã¯åžžæè²äœå£æ§éºäŒåçŸæ£ã®äžçš®ã§ããæ人æ©èçã
WS ãšããããŸãã
å£æ»
çããçµç¹ãæ»ã¬ããšã
ãšãã«ãã·ã³
ãªã³ãç¯è»¢ç§»ã䌎ãæ©æã®ä¹³çã®æ²»çè¬ãšããŠä»å€ãšäœµçšããŠäœ¿çšãããè¬å€ã§ãããã®ä»
ã®çãžã®æ²»çã«ãæ€èšãããŠããŸãããšãã«ãã·ã³ã¯ã¢ã³ãã©ãµã€ã¯ãªã³ç³»æè «çæ§æçç©
質ã§ãããšã¬ã³ã¹ããšãã«ãã·ã³å¡©é žå¡©ãšãåŒã°ããŸãã
å¡©åãããŒã«
ãã©ã¹ããã¯ã®è£œé ã«äœ¿çšãããåæãå¡©åãããŒã«ãžã®è¢«ã°ãã¯ãèèè «çãè³è «çãèº
ããããªã³ãè «*ãçœè¡ç ãçºçãããªã¹ã¯ãé«ããå¯èœæ§ããããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 29
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
暪çŽçèè «
垯ç¶çãšããçèã®è»çµç¹ã«åœ¢æãããããã§ãå šèº«ã©ãã«ã§ãçºçããŸãã
ãªããªã€ãïŒã¢ãã³æ§åæ麻é è¬ïŒ
äžç床ããæ¿ããçã¿ã®æ²»çã«äœ¿ãè¬å€ããªããªã€ãã¯ã¢ã«ãã*ãã³ãã€ã³ã®ãããªã¢ã
ã³è¬ãšåæ§ã§ãããã¢ãã³ããã¯äœãããŸãããäžæ¢ç¥çµç³»ã«ãããªããªã€ãå容äœã«çµå
ããŸãããªããªã€ãã¯éº»é è¬ãšåŒã°ããŠããŸããããªããªã€ãã¯ã¢ã«ã«ãã€ãïŒå«çªçŽ ææ©
ååç©ïŒã®ã²ãšã€ã§ãã
ååŠçæ³
è¬å€ã«ããç现èãæ»æ» ãããè «çã®å¢æ®ãæå¶ããçæ²»çã®äžçš®ã§ãããããã®è¬å€ã¯é
åžžãæ£è ããã®éèå ãžç·©åŸã«æ³šå ¥ãããŸãããçã®å±åšã«ãã£ãŠã¯ãçŽæ¥ãæ足ã§ãã£ã
ãããšãã«ã¯èèã§ãã£ãããçµå£æäžãã§ãããã®ããããŸãã
æ»èçµç¹
é¢ç¯ãåãå²ãèãæ§æããèããŠç·©ãããªè¡ç®¡çµåçµç¹ã§ãããè ±ãä¿è·ããéã骚ã®çª
åºéšãééããå Žæã§ããæ»è现èã¯é«æ¶²ãåæ³ããŸãããããã¯é¢ç¯è»éªšè¡šé¢ã«æœ€æ»æ§ã
äžããæ é€è£çµŠãè¡ã£ãŠããŸãã
æ»èèè «
é¢ç¯ã®æ»èã«çºçããæªæ§è «çã§ãã
ã«ãã§ãªã¬è²çŽ æ²ç
æ·¡è€è²ã®è²çŽ æã§ãã«ãã§ãªã¬è²ã«äŒŒãŠããããšããããã®ããã«åŒã°ããŸãã
ã«ããžèè «
ç å€ïŒç°åžžãªé åïŒãç®èããªã³ãç¯*ãå£è ã錻ãåãããã³äœã®ãã®ä»ã®çµç¹ã«ãçºç
ããã¿ã€ãã®çãç å€ã¯é垞玫è²ã§ããã现èãè¡ç®¡ãè¡çã§ã§ããŠããŸããäœã®è€æ°ã®ãš
ããã«åæã«çºçããããšããããŸããã«ããžèè «ã¯ãã«ããžèè «é¢é£ãã«ãã¹ãŠã€ã«ã¹ïŒ
KSHVïŒã«ãã£ãŠåŒãèµ·ããããŸãã西æŽè«žåœã§ã¯ãéåžžãAIDS ææãèåšç§»æ€ã®å ç«äœ
äžç¶æ 人ã«èµ·ããããšãå€ãããŠãã€ç³»ãå°äžæµ·ç³»ã®é«éœ¢è ãã¢ããªã«ã®è¥å¹Žè ã«ãèŠãã
ãŸãã
èèã®ïŒHepaticïŒ
Hepatic ã¯ãèèã®ããšããæå³ãHepatic vein(èéè)ã¯èèããè¡æ¶²ãå€ãžæåºããé
èã§ããHepatic disease(èèç )ã¯èèã«åœ±é¿ããçŸæ£ã§ãã
å€æ¥æ£è
éé¢ã§ã蚺æãæ²»çãåããæ£è ããã®ããšã§ãã
åºåºçŽ°èæ¯æççå矀
é¡ã«ç¹åŸŽçãªå€è²ãèµ·ããã»ããç®èã骚ãç¥çµç³»ãçŒãå åæ³è ºã«ç°åžžãèµ·ããéºäŒæ§çŸ
æ£ãæ£è ããã¯ãç®èåºåºèããã®çºçãé«ããªããŸãããŽãŒãªã³çå矀ãæ¯ææ§åºåºçŽ°è
ççå矀ãšãåŒã°ããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 30
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èžè
èºã®è¡šé¢ãšèžè ã®å å£ã®è¡šé¢ãèŠã£ãŠããèãèãèºãä¿è·ããèºã«ãããè¡æãåãããŠ
ããã最æ»å€ãšããŠåã液äœãå°éåæ³ãããŠãããããåŒåžãããéã«èºãèžè å ã§æ»ã
ãã«åãããã«ãªã£ãŠããŸãã
å±æåé€
ç å€ãåé¡ã®ããçµç¹ã®å°ããªé åãšäžç·ã«ããã®åšèŸºã®æ£åžžçµç¹ãåãé€ãå€ç§çææã
ãã®åŠçœ®ã¯ãäžè¬çã«ä¹³æ¿ãç®èã®ç å€ã«å¯ŸããŠè¡ãããããšãå€ãã§ãããå šèº«ã®éšäœã§
è¡ãããšããããŸãã
çŠå¿
æ£è ãããžæ瀺ãããæ²»çãåŠçœ®ãè¡ããªãç¶æ ãçç¶ãçŠå¿ã«ã¯çµ¶å¯ŸççŠå¿ãšçžå¯ŸççŠå¿
ãããã絶察ççŠå¿ã¯ãã®ãããªç¶æ ãçç¶ãæããæ£è ããã«ãã®æ²»çã決ããŠããã¹ã
ã§ãªããšããããšãæå³ããŠãããçžå¯ŸççŠå¿ã¯ãã®ãããªç¶æ ãçç¶ãæããäœäººãã®æ£
è ããã«å¯Ÿããå©çãå±éºã«åããšããããšãæå³ããŠããŸãã
è¡ç®¡èè «
è¡ç®¡è ããªã³ã管ã«äžŠã¶çŽ°èç±æ¥ã®çã®åãè¡ç®¡è ã«äžŠã¶çŽ°èç±æ¥ã®çã¯ãè¡ç®¡èè «*ãšåŒ
ã°ããŸãããªã³ã管ã«äžŠã¶çŽ°èç±æ¥ã®çã¯ãªã³ã管èè «ãšåŒã°ããŸãã
è¡å°æ¿
è¡æ¶²ååºã«ãããŠãåºæ¬çãªåœ¹å²ãæ ãå°ããªçŽ°èæçãè¡å°æ¿æ°ãäœãæ£è ã¯ãé床ã®åº
è¡ã®å±éºã«ãããããŸããé«å€ã®å Žåã¯è¡æ çã®å±éºããããè¡æ 圢æã«äŒŽãè¡ç®¡éå¡ã«ã
ããè³åäžãŸãã¯é節ãªç¶æ ã«é¥ãããšããããŸãããŸããè¡å°æ¿ã®æ©èœäžå šã®å Žåãé床
ãªåºè¡ã®å±éºã䌎ãããšããããŸãã
çµç¯æ§ç¡¬åç
è èãè³ãçŒãå¿èãèºãç®èã«è¯æ§ïŒããã§ãªãïŒè «çã圢æãããéºäŒæ§çŸæ£ããã®çŸ
æ£ã¯ãçºäœã粟ç¥é害ãæ§ã ãªçš®é¡ã®ç®èçŸæ£ãåŒãèµ·ããå¯èœæ§ããããŸãã
ã²ã ã·ã¿ãã³
é²è¡ãŸãã¯è»¢ç§»ããèµããã®æ²»çã«äœ¿çšãããè¬ç©ã®æŽ»æ§æåããŸãã転移ããä¹³ãããé²
è¡ããåµå·£ãããé²è¡ãŸãã¯è»¢ç§»ããéå°çŽ°èèºããã®æ²»çè¬ãšããŠä»ã®è¬ç©ãšäœµçšããã
ããšããããä»ã®çš®é¡ã®ããã«å¯Ÿããæ²»çè¬ãšããŠãç 究ãããŠãããã²ã ã·ã¿ãã³ã¯ãã
现èã® DNA åæãé»æ¢ã殺å·ããŸãã代è¬æ®æè¬ã®äžçš®ã§ãã
å¹»è¢ç
倱ã£ãåè¢ã®éšäœã«æããçã¿ãç°åžžæèŠã®ç·ç§°ã
å£è ç²è
å£è å ã®æ¹¿æœ€ãªè¡šç®ãç²èå ã®åæ³è ºã®ããã«ãåã¿ãæã¡ããªãããã«ãªã£ãŠããŸããç²
液æ§ã®èãšãèšãæããããšãã§ããŸãã
å£è ç²èç
ããçæ³ã®æ害äºè±¡ãšããŠãå£è ç²èãççãçã¿ãèµ·ãããç¶æ ã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 31
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ鬱ïŒãã€ïŒå€
ãã€ç ã®æ²»çã«äœ¿ãããè¬ã§ãã
奜äžçæžå°
çœè¡ç*ã®äžã€ã§ãã奜äžçãæ£åžžããå°ãªããªã£ãŠããç¶æ ããŠã£ã«ã¹ææãæŸå°ç·ãå
åŠçæ³*ã®æ²»çã®åŸã§ã¿ãããããšããããŸãã奜äžçæžå°ã¯çŽ°èãçèææã®å ç«åŠçé²
埡èœã匱ããããšã«ãªããŸãã
æããããè¬
ãŠãããçºäœããããããäºé²ããããæ¢ããããã«äœ¿ãããŸããæãŠãããè¬ãšãåŒã°ã
ãŸãã
åŸè ¹è
è ¹è ã®åŸéšã«äœçœ®ãã空éã§ãè ¹èãšåŒã°ããçµç¹å±€ã®åŸãã«ãããè °éšïŒè ¹è ã®åŸå£ïŒã
圢æããçèããã³éªšã®åæ¹ã«ãããŸããè ¹èã®èåŸã«ããå šãŠã®åšå®ãã€ãŸãåŸè ¹èå ã®
åšå®ã¯ããããåŸè ¹èåšå®ãšãªããããã«ã¯ãè èãèµèãçµè žãªã©ãå«ãŸããŸãã
åŸè ¹èèè «
骚ãšè»éšçµç¹ã«çºçããããã®äžçš®ã§ãè»éªšãèèªãçèãè¡ç®¡ãç·ç¶çµç¹ãªã©ã®ä»ãçµå
çµç¹ãæ¯æçµç¹ãçºçå Žæã«å«ãŸããŸããããã®åœ¢æå Žæã«åºã¥ããŠèè «ã®çš®é¡åãããã
ãŠããŠãåŸè ¹èèè «ã¯ãè ¹è ã®åŸæ¹ã«çºçãããã®ãæããŸãã
éªšè «
æ°ããªéªšã圢æããè «çã§ãé è骚ã«å€ããè¯æ§è «çã§ãã
骚èè «ïŒOsteosarcomaïŒ
äžè¢ãäžè¢ã®åè¢ã®å€§ããé·ç®¡éªšã«çºçãã骚ã®çãè¥å¹Žè ã«ãããç·æ§ã«å€ãã§ããè±èª
ã®å¥åã¯ãOsteogenic sarcomaã
å€ç«ç·ç¶æ§è «çïŒSFTïŒ
èžèãŸãã¯å šèº«ã®è»éšçµç¹ã«çºçããçšãªè «çã§ãè¯æ§ã§ãæªæ§ã§ãããåŸãŸãã
åçº
éåžžã¯ããããçŸæ£ãèªããªããæ€åºã§ããªãæéããã°ããç¶ããåŸã«ãåã³çºçããã
ããçŸæ£ã®ããšãåçºã¯æåã«çºçããïŒåçºïŒè «çãšåãéšäœã«åçºããå Žåãããã°ã
å¥ã®éšäœã«åçºããå ŽåããããŸããåçºãããåçºæ§çŸæ£ãšãåŒã°ããŸãã
åå®®å èé質èè «
åå®®å ã®çµç¹ããçããèè «ã®äžçš®ã
ã·ã¯ããã¹ãã¡ãã
æ§ã ãªçš®é¡ã®ããã®æ²»çã«çšããããèšåºç 究ãè¡ãããŠããè¬ã幌å ã®è èç ã®æ²»çã«ã
çšããããŠããŸããã·ã¯ããã¹ãã¡ããã¯çŽ°èå ã® DNA ã«çµåãããã现èãæ»æ» ãããŸ
ããã¢ã«ãã«åå€ã®äžçš®ã§ãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 32
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ã·ã¹ãã©ãã³
æ§ã ãªçã®æ²»çã«çšããããè¬å€ãã·ã¹ãã©ãã³ã«ã¯éå±çœéãå«ãŸããŠããŸããDNA é
害㚠DNA ã®åè£ãé»å®³ããããšã§ç现èãæ»æ» ãããŸããã·ã¹ãã©ãã³ã¯ã¢ã«ãã«åå€ã®
äžçš®ã§ãã
èèªèè «
èèªæ§ã®çšãªæªæ§è «çã
éåŠçæ²»ç
å€çš®å€æ§ãªæ²»çæ¹æ³ãçµã¿åãããçæ³ã®ããšã䜵çšçæ³ãéåŠççæ³ãšãåŒã°ããŸãã
è «çé°æ§ã®åé€çž
ããæè¡ã®åé€åŸãæšæ¬ã®çµç¹èŸºçžã蟺çžãç çå»*ãçµç¹ã®èŸºçžã«è «ç现èãçºèŠããªã
ã£ãå Žåã«ã¯ãæ±æãããŠããªãç¶æ³ã§å®å šã«åé€ã§ãããšè©äŸ¡ãããŸããè «ç现èã確èª
ããæ®åããŠããç¶æ³ã¯ãéœæ§åé€çžãäžå®å šåé€ãšåŒã°ããŸãã
è «çå ç§å»
ååŠçæ³*ããã«ã¢ã³çæ³ãçç©åŠççæ³ãååæšçè¬çæ³ã䜿ã£ãããæ²»çãå°éãšãã
å»åž«ãè «çå ç§å»ãäžå¿ãšãªã£ãŠãããã«ããã£ãŠããæ¹ãžå»åŠçãªæ å ±ãæäŸããããšã¯
ãã°ãã°ã§ãç·©åã±ã¢ãéåŠæ²»çã®ã³ãŒãã£ããŒã¿ãŒçãªåœ¹å²ãæ ã£ãŠããŸãã
è «çæå¶éºäŒå
现èå¢æ®ãã³ã³ãããŒã«ããè «çæå¶ã¿ã³ãã¯è³ªãšããã¿ã³ãã¯è³ªãäœãéºäŒåã®äžçš®ã®ã
ãšã§ããè «çæå¶éºäŒåã®çªç¶å€ç°ïŒDNA ã®å€åïŒã¯ããã«ã€ãªããå¯èœæ§ããããŸãã
ããæå¶éºäŒåãšãåŒã°ããŸãã
å°å è «çå»
å°å çæ²»çã®å°éå»ã
æ¶å管éè³ªè «çïŒGIST)
èæ¶å管å£ã®çŽ°èããçºçããè «çã§ãè¯æ§ãæªæ§ãšãã«ãããŸãã
æ¶å管éå¡ãèè žéå¡ãã€ã¬ãŠã¹
èãè žãéå¡ãè©°ãŸã£ãç¶æ ã
éèå
éèã®äžãžãéèã®äžã®ããšããæå³ãéèå ãšããçšèªã¯éåžžãéèå ã«æ¿å ¥ããéã管
ãéããŠè¬å€ãªã©ã®ç©è³ªãæäžããæ¹æ³ãæããŠçšããããŸãããIVããšãåŒã°ããŸãã
ç¥çµè è «
ã°ãªã¢çŽ°èïŒç¥çµçŽ°èãåãå²ãã§æ¯æãã现èïŒããçããè³å ã®æªæ§è «çã
ç¥çµéè «
ç¥çµéïŒç¥çµãèŠã£ãŠããããïŒã«çºçããæ«æ¢¢ç¥çµç³»ã®è «çã§ãã»ãšãã©ã®å Žåè¯æ§ã§ã
ããçšã«æªæ§ç¥çµéè «ãå ±åãããŠããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 33
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç¥çµç·ç¶è «
ç¥çµãèŠã现èãçµç¹ããçºçããè¯æ§è «çã
ç¥çµç·ç¶è «çïŒéºäŒåïŒNF1 éºäŒå
NF1 éºäŒåã¯ããã¥ãŒããã£ãããã³ãšããã¿ã³ãã¯ç£çã«é¢äžããŠããéºäŒåã§ããã
ã®ã¿ã³ãã¯è³ªã¯ãç¥çµçŽ°èããªãªãŽãã³ãããµã€ãïŒåžçªèµ·ç¥çµè 现èïŒãç¥çµãåãå²ã
ã§ããã·ã¥ã¯ã³çŽ°èã«å€ãçºçŸããŠããŸãã
ç¥çµæ¯æ§
ããçš®ã®æ²»çã«ãããç¥çµç³»ã«æå·ãäžããåŸåã
æ·±éšéèè¡æ
足ãäžéšéªšç€ã®æ·±ãéèã«åè¡å¡ã圢æããããšãçã¿ãè «è¹ãç±æãçºèµ€ãšãã£ãçç¶ã
æ£éšã«èŠãããããšããããŸããDVT ãšãåŒã°ããŠããŸãã
é«èè «
é«èïŒè³ãšèé«*ãèŠãä¿è·ããŠããèãçµç¹ïŒã«çºçããç·©åŸã«æé·ããè «çãé«èè «ã¯
éåžžæ人ã«çããŸãã
æŽåœ¢å€ç§å»
éªšæ Œçç³»ã«çºçããå€å·ãç æ°ã®èšºææ²»çãå°éãšããå€ç§å»ã骚ãé¢ç¯ãè ±ãé垯ãçè
ã察象ãšããŠããŸãã
çæ€
ç çå»ã«ããæ€æ»ã®ããã«çŽ°èãŸãã¯çµç¹ãæ¡åããããšãç çå»ã¯ãã®çµç¹ãé¡åŸ®é¡ã§èª¿
ã¹ããããã®çŽ°èãŸãã¯çµç¹ã«å¯ŸããŠä»ã®æ€æ»ãå®æœãããããŸããçæ€ã®ææã«ã¯æ§ã ãª
çš®é¡ããããŸããæãäžè¬çãªãã®ãšããŠã¯ä»¥äžã®ãã®ããããŸãïŒïŒ1ïŒåéçæ€ãçµç¹
ã®ãµã³ãã«ã ããæ¡åããæ¹æ³ïŒïŒ2ïŒæåºçæ€ãããããçãããé åã®å šäœãæåºãã
æ¹æ³ïŒïŒ3ïŒéçæ€ãçµç¹ãäœæ¶²ã®ãµã³ãã«ãéãçšããŠæ¡åããæ¹æ³ã倪ãéã䜿çšãã
å Žåã¯ãã³ã¢çæ€ãšåŒã°ããã现ãéã䜿çšããå Žåã¯ãç©¿åºåžåŒçæ€ãšåŒã°ããŸãã
å¶åå€
æããå€ã®æ²»çã«äŒŽãåæ°ãååãäºé²ã軜æžããè¬å€ãã°ã©ãã»ããã³ãã¡ãã¯ããã©ã
ãããªã³ãã³ã»ããã³ãå«ãŸããŸãã
èµ€è¡ç
æãäžè¬çãªè¡çãè¡æ¶²ãèµ€ãèŠããç©è³ªãé žçŽ ã®èŒžéãäž»ãªåœ¹å²ã§ãã
ç·ç¶èœçŽ°è
ã³ã©ãŒã²ã³ã¿ã³ãã¯è³ªãäœãåæ³ããçµåçµç¹çŽ°èã
ç·ç¶è «
è¯æ§è «ç*ãéåžžåå®®ãŸãã¯èè žç®¡ã«ãããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 34
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç·ç¶è «ç
è€æ°ã®ç·ç¶è «ãçºçããç¶æ ã ç·ç¶è «ã¯ãçµåçµç¹ã«åœ±é¿ããããŒãè¯æ§è «çã§ãã
å šèº«æ²»çã»çæ³
è¡æµãéããŠåŸªç°ããç©è³ªãçšããå šèº«ã®çŽ°èã«è¡ãããããå¹æãäžããæ²»çãååŠçæ³
ãå ç«çæ³ã¯ãå šèº«çæ³ã®äžäŸã
çµç¹ç çïŒçµç¹ç çåŠ
é¡åŸ®é¡ã䜿ã£ãŠãçµç¹ã现èãæ€æ»ãç 究ããããšãçæ€*ãæè¡ã§ãæ¡åãããçµç¹ãåº
å®åŸãæ€æ»å®€ã«éããç®åæšæ¬ãäœæããåçš®ã®æè²ãè¡ã£ãäžã§ãé¡åŸ®é¡ã§èŠ³å¯ããŸãã
ãŸã³ãïŒãããŒã
äœã®å·ã空æŽãç©Žãªã©ãæ€çŽ¢ããé·ããŠçŽ°ãåšå ·ã
ãã€ãªãã·ã³
éåžžã«ææ¯ã§ããããšãç¥ãããŠããæ§ã ãªå·¥æ¥å»æ£ç©ã
å€§è žè ºè «æ§ããªããŒã·ã¹ïŒAPCïŒéºäŒå
ããæå¶éºäŒåãéºäŒåå€ç°ãçµè žçŽè žãããèµ·ãããŸãã
ãã«ã«ããžã³
ããžãã³ãªã³ãè «*ãæªæ§é»è²è «ã®æ²»çã«äœ¿çšãããä»ã®çš®é¡ã®çã®æ²»çã«ãããŠãç 究ã
ãããŠããæ²»çè¬ã§ãã现èå ã® DNA ã«äœçšããŠãç现èã殺ããšãããŠããŸããã¢ã«ã
ã«åå€ã®äžçš®ã§ãã
ã¿ããµã³
现èåè£ãæ¢ããããšã«ããã现èã®æé·ãé»å®³ããè¬ã®äžã€ãã¿ããµã³ã¯åŸ®å°ç®¡ïŒæ糞å
è£ã«ãããŠæè²äœã®ç§»åãå©ãã现èå æ§é ç©ïŒã劚害ããããšãããããæ²»çã«çšããã
ãŸããæ糞åè£é»å®³å€åã³åŸ®å°ç®¡é»å®³è¬ã®äžçš®ã
泚ææ·±ãåŸ æ©
æ£è ããã®ç¶æ ã泚ææ·±ã芳å¯ããéãçç¶ãçŸãããå€åããªãéããæ²»çãäžããªãã
ãšãæå³ããŸãããããã¯ãç ç¶ããã£ãããšé²è¡ããå ŽåããããŠãæ²»çã®ãªã¹ã¯ãæç
æ§ããé«ãå Žåã«è¡ããŸãã泚ææ·±ãåŸ æ©äžã«ãæ£è ããã«ã¯ããçš®ã®æ€æ»ãè¡ãããããš
ããããŸããåç«è ºçã§æã è¡ãããå芳ã»åŸ æ©ãããžã¡ã³ããšããããããããŸãã
è¶ é³æ³¢
é«ãšãã«ã®ãŒã®é³æ³¢ãäœå ã®çµç¹ãèåšã«åœãŠãŠåé¿ãäœãåºãææ³ãåé¿ã®ãã¿ãŒã³ã¯è¶
é³æ³¢è£ 眮ã®ã¹ã¯ãªãŒã³ã«è¡šç€ºãããäœå çµç¹ã®ç»åãè¶ é³æ³¢ç»åãšããŠè¡šç€ºãããŸãã
èŽç¥çµ
èŽèŠããã©ã³ã¹ãé ã®äœçœ®ã«é¢ããç¥çµã®ããšã§ãããã®ç¥çµã«ã¯ãèžçæïŒé³äŒéïŒãšå
åºæïŒãã©ã³ã¹æèŠãé ã®äœçœ®æèŠãæç¥ïŒãšãã 2 æ¬ã®åå²ããããŸããå è³ç¥çµãšã
åŒã°ããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 35
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
転移
身äœã®ããå Žæããä»ã®å Žæãžãšãããæ¡ããããšãæ¡ãã£ã现èã«ãã£ãŠåœ¢æãããè «ç
ã¯è»¢ç§»è «çã転移ãšåŒã°ããŸããè»¢ç§»è «çã¯åçºã®è «çãšããªã现èãå«ã¿ãŸãã
é»é¢æŸå°ç·ç §å°
X ç·*è£ çœ®ãæŸå°ç·æ§ç©è³ªãå®å®ç©ºéããå°çã«å ¥ã£ãŠããæŸå°ç·ããã®ä»ã®åå ã«ãã£ãŠ
çããïŒæŸåºãããïŒæŸå°ç·ã®ã²ãšã€ã®åãé«ç·éã§é»é¢æŸå°ç·ç §å°ã¯çŽ°èå ã§ååŠæŽ»æ§ã
å¢å ãããçãå«ãå¥åº·ã«å±éºãçãããå¯èœæ§ããããŸãã
çªç¶å€ç°
éºäŒåã圢æãã DNA ã«ãããŠãå¡©åºå¯Ÿã®äžŠã³ãå€åããããšãéºäŒåå€ç°ã«ãããå¿ ã
ããéºäŒåãæ°žä¹ çã«å€åããããã§ã¯ãããŸããã
ãã©ãã¯ããžã³
ãã€ã®äžçš®ããæœåºããããããæ²»çã®ããã«ç 究ãããŠããç©è³ªã§ããDNA ã«çµåãã
DNA ãç Žå£ããŸããDNA æå·ã修埩ãã现èã®èœåããããã¯ãããããç现èãæ»æ»
ãããããšãã§ãããšãããŠããŸãããã©ãã¯ããžã³ã¯ç 究æã§ãäœãããŠãããããã¯
DNA åé€ä¿®åŸ©é»å®³å€ã®äžçš®ã§ãã
ãããœã«ãã·ã³
æ§ã ãªçš®é¡ã®ããã®æ²»çã«çšããããèšåºç 究ãè¡ãããŠããè¬ã§ãããããœã«ãã·ã³ã¯
Streptomyces å±ã®çŽ°èããåé¢ãããŸããDNA ãç Žå£ãããã现èãæ»æ» ãããŸããã¢
ã³ãã©ãµã€ã¯ãªã³æè «çæçç©è³ªã®äžçš®ã§ããã¢ããªã¢ãã€ã·ã³ PFS ãã¢ããªã¢ãã€ã·ã³
RDFãå¡©é žãããœã«ãã·ã³ãšãåŒã°ããŸãã
ãã»ã¿ãã»ã«
ãã»ã¿ãã»ã«ã¯ã¿ããµã³ãšããŠç¥ãããŠããæããå€ã«å±ããŸãããã»ã¿ãã»ã«ã¯çŽ°èãå
åå¢æ®ããããã«å¿ èŠãªå éšéªšæ Œãç Žå£ããèœåãé»å®³ããŸããéªšæ Œããã®ãŸãŸã ãšçŽ°èã¯
åè£ããããšãã§ãããæçµçã«æ»ã«è³ããŸãããã»ã¿ãã»ã«ã¯è¡çã®ãããªéãã现èã«
ã圱é¿ãåãŒãããããããå¯äœçšã®åå ãšãªãããšããããŸãã
èè «
骚ãè»éªšãèèªãçèãè¡ç®¡ãã®ä»ã®çµåçµç¹*ãŸãã¯æ¯æçµç¹ã®çã
å ¥é¢æ£è
ç é¢ã«æ³ãŸã£ãŠæ²»çãåããæ£è ãããå¯Ÿç §çãªèšèã¯å€æ¥æ£è *ã
ç²èç
çæ²»çã®å䜵çã§ãæ¶å管ã®ç²èãççãèµ·ãããç¶æ ãå£è ã®çã¿ã®åå ãšãªããŸãã
çºããç©è³ª
ããçºçãèªçºããç©è³ªã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 36
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
çœè¡ç
ææãã身äœãå®ã圹å²ãæ ããå ç«ç³»*ã®çŽ°èã
ãã¯ãªã¿ãã»ã«
ä¹³ãããåµå·£ãããAIDS*é¢é£ã®ã«ããžèè «ã®æ²»çã«çšããããè¬ãåå®®é žãããæ²»çãã
éãä»ã®è¬ãšäœµçšããŠçšããããããšããããŸãããŸãããã¯ãªã¿ãã»ã«ã«é¢ããŠä»ã®ãã
æ²»çã®ç 究ãè¡ãããŠããŸãã现èåè£ãæ¢ããããšã«ãã现èã®æé·ãé»å®³ãããã现è
ãæ»æ» ãããŸããææ糞åè£è¬ã®äžçš®ã§ãã
ããŸããã
æãäžè¬çãªã¿ã€ãã®è èçã§ããé²è¡è 现èçã®æ²»çã«äœ¿çšãããè¬å€ãä»ã®æçå€ã§æ²»
çãããåŸã®é²è¡è»éšèè «ã®æ²»çã«ã䜿çšãããŸãããã®ä»ã®ã¿ã€ãã®çã®æ²»çã«é¢ããŠã
ç 究ãé²ããããŠããŸããå¡©é žããŸãããã¯ãã¿ã³ãã¯è³ªããã·ã³ãããŒãŒé»å®³å€ã®äžçš®ã§
ãè¡ç®¡æ°çãé»å®³ããè «çã®æé·ã劚ããŸãã
æšçæ²»çã»çæ³
ç¹å®ã®ãã现èãèŠã€ããæ»æããããã«ã¢ãã¯ããŒãã«æäœãªã©ã®è¬å€ãç©è³ªã䜿çšãã
æ²»çæ³ãæšçæ²»çã¯ä»ã®ããæ²»çæ³ããå¯äœçšãå°ãªãããšããããŸãã
è¡šç®å¢è «ãäžç®å¢è «
ç®èå€å·ã§ãäžç®ãçµç¹å ã«è¢ç¶ã«ãã±ãããäœããå¢è «ç¶ã«ãªã£ãè «çãå 容ç©ã¯æ¶²äœã
空æ°ãäžç®ã®å¢ã液äœãªã©ã§ãã»ãšãã©ã®å¢è «ã¯è¯æ§ïŒããã§ã¯ãªãïŒã§ãã
貧è¡
èµ€è¡ç*ãŸãã¯ãã¢ã°ããã³*ã®äžè¶³ã«ãã£ãŠç¹åŸŽä»ããããç¶æ ããã¢ã°ããã³ãå«ãéã¯
èºããå šèº«ãžãšé žçŽ ãéã³ãŸããã貧è¡ç¶æ ã§ã¯ãã®é žçŽ éæ¬ã¯æžå°ããŸãã
ããã¬ã«ãã³
ãã³ã«ã¢ã«ã«ãã€ããšåŒã°ããæ€ç©è¬ã®äžçš®ã®æçå€ã
ç çå»
é¡åŸ®é¡ã䜿ã£ãŠçŸæ£ã®çŽ°èãçµç¹ãæ€èšããç ççµç¹åŠ*ãå°éãšããå»åž«ã®ããšã
ãã³ã¯ãªã¹ãã³
æ¥æ§çœè¡ç ã®æ²»çã«çšããããè¬å€ã§ããããžãã³ãªã³ãè «ãéããžãã³ãªã³ãè «ã暪çŽç
èè «ãç¥çµèœè «ããŠã£ã«ã ã¹è «çã®æ²»çã«ä»ã®è¬å€ãšäœµçšããŠäœ¿ãããŸãããã³ã¯ãªã¹ãã³
ã¯ä»ã®ããã®æ²»çã«ãããŠãç 究ãããŠããŸãã现èåè£ãäžæ¢ããããšã§çŽ°èå¢æ®ãæå¶
ããŸãããã³ã«ã»ã¢ã«ã«ãã€ããšææ糞åè£è¬ã®äžçš®ã§ãã
ãã¡ãããŠã¹ç®¡
åµå·£ããåå®®ã«åµèãéã¶çŽ°ã管ã女æ§çæ®ç³»èåšã§ã察ã®åµå·£ã茞åµç®¡ã¯ãåå®®ã®å·Šå³é
眮ãããŠããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 37
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
éçµ
ç涯ã«ãããŠã女æ§ã®åµå·£ããã«ã¢ã³çæãåæ¢ããæçµåšæãæ¢ãŸãææãèªç¶éçµã¯é
åžž 50 æ³é ã«èµ·ãããŸãã12 ãæé£ç¶ããŠççã蚪ããªãã£ãå Žåããã®å¥³æ§ã¯éçµãè¿
ãããšèšããŸããéçµã®çç¶ã¯çŽ 朮ãæ°åã®å€åãå¯æ±ãè£ä¹Ÿç¥ãéäžåã®æ¬ åŠãäžåŠãæ
ããããŸãã
䟿倱çŠ
æ䟿ã³ã³ãããŒã«ã®äžå ·åã§ã䟿ãæŒããç¶æ ã
ãã§ããã·ç³»é€èå€
ãã§ããã·ç³»é€èå€ã¯ãæé·ãã«ã¢ã³ã§ããã€ã³ããŒã«é ¢é žïŒIAAïŒã«é¢é£ããååŠç©è³ªã®
äžçš®ã§ããåºèæ€ç©ã«åŽé§ãããšãæ¥éã§ã³ã³ãããŒã«äžèœãªæé·ãèªçºããæçµçã«ã¯æ€
ç©ãæ¯ããŠããŸããŸãã
ãã©ã³ã¬ã¯ãªã³ã°ããŠãŒã³ç
ç¥çµç·ç¶è «ç 1 ãšããŠç¥ãããç æ°ã§ãã
æµ®è «
ç®äžãäœå ãäœè ã«æ¶²äœãç°åžžã«æºãŸã£ãç¶æ ã
ãããŠç³
ãããŠç³ã¯æ€ç©ãåç©ã®çµç¹ã§åºãäœãããåç³é¡ãäœã®äž»ãªãšãã«ã®ãŒæºã«ãªããŸãã
åé¢åŒæž©ç±æ£è¢çæµæ³
æããå€ã溶ãããå æž©ãã溶解液ããäžè¢ãäžè¢ã®è¡ç®¡ã«æµãããæ²»çæ¹æ³ãã¿ãŒãã±ã
ãïŒåè¢ã®è¿äœéšãçžããã«ãïŒã§äžæçã«åè¢ã®è¡æµãæ¢ããŠãåè¢ã®è¡æ¶²å ã«æããå€
ãæäžããæ¹æ³ã§ããæªæ§è «çãçºçããŠããå±æã«å€§éã®æããå€ãæäžããããšãã§ã
ãæ¹æ³ã§ãåè¢çæµæ³ãšãåŒã°ããŸãã
åè£é床ã»æ°
ãã现èãã©ã®ãããéãåè£ããæé·ããŠãããããããã尺床ãäžå®éã®ããçµç¹ã®äž
ã§åè£ãã现èæ°ãæ°ããããšã«ãã£ãŠãåè£é床ã確èªããããšãã§ããŸããåè£é床ã¯
é»è²è «ïŒç®èçã®äžçš®ïŒãä»ã®ããã€ãã®çš®é¡ã®ããã®ç æå€å®ã«å©çšã§ããåè£æ°ãé«ã
ãšçåçãäœããªããŸãã
å¹³æ»çèè «
å¹³æ»ç现èã®æªæ§è «çïŒããïŒã§ãäœã®ã»ãŒã©ãã«ãçºçããŸãããäžè¬ã«ãåå®®ãè ¹éšã
骚ç€ã«å¥œçºããŸãã
æŸå°æ§æšè
æŸå°æ§ç©è³ªã§æšèããããšãæŸå°æ§æšèãããç©è³ªãäœå ã«æ³šå ¥ããããšããã®ç©è³ªã®åã
ã¯æ€åºåšã«ãã£ãŠè¿œè·¡ããããšãã§ããŸãã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 38
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æŸå°ç·ç§å»
ã¬ã³ãã²ã³*æ®åœ±è£ 眮ãCT*ãMRI*æ€æ»çã®ç»åæ©åšã䜿ã£ãŠãçŸæ£ãå€å·ã®èšºæãè¡ãå°
éå»åž«ã
æŸå°ç·æ€æ»
蚺æãšæ²»çã®äž¡æ¹ã®ãããäœå ã®èåšãæ§é ãçµç¹ãèŠèŠåããç»åæè¡ïŒX ç·æ®åœ±ãè¶ é³
æ³¢*ãã³ã³ãã¥ãŒã¿æå±€æ®åœ±æ³*ãæ žå»åŠãªã©ïŒãçšããæ€æ»æ³ã
æŸå°ç·è «çå»
æŸå°ç·ã§ãããæ²»çãè¡ãå°é家ãç»åæ€æ»ã§èšºæãè¡ãæŸå°ç·èšºæå»*ãšã¯ç°ãªããŸãã
æŸå°ç·æ²»ç
ããã®ç¹å®ã®é åã察象ãšããããæ²»çã«çšããããæŸå°ç·æ²»çã
èè±æ§å°¿å€±çŠ
æå°¿ã³ã³ãããŒã«ã®äžå ·åã§ãå°¿ãæŒããç¶æ ã
ãã«ã¢ã³çæ³
ãã«ã¢ã³ã䜿ã£ãæ²»çã®ããšã§ãã
èïŒçŽ°èèãéå£èïŒ
çç©åŠã«ãããŠã¯ãïŒïŒïŒçŽ°èå ã®æ§é ç©ãå ã¿èŸŒãã§ããèæ§é ãïŒïŒïŒåšå²ã®çµç¹ãã
现èãéé¢ããŠãã现èåšå²ã®å±€ãïŒïŒïŒçµç¹éã«ãã£ãŠãçµç¹ã®å¢ã圢æããŠããèïŒåº
åºèãç²èïŒã
麻é
麻é è¬ãšããŠç¥ãããŠããè¬å€ã䜿çšããããšã§ãå¯éçã«æèã®ãªãç¶æ ãšããçã¿ãé€
ããæ£åžžãªåå°ãæããã¹ãã¬ã¹ã«å¯Ÿããåå¿ã匱ããŸããå šèº«éº»é ãå±æ麻é ãè¡ãããš
ã«ãã£ãŠãæ£è ããã«å€ç§çåŠçœ®ãå¯èœãªç¶æ ã«ããŸãã
æ«æ¢¢ç¥çµéè «çïŒMPNSTïŒ
æ«æ¢¢ç¥çµåšå²ã®ä¿è·éïŒè¢«èŠïŒã圢æããäžæ¢ç¥çµç³»ã®å€ã«ããç¥çµïŒè³ããã³èé«ïŒã§ã
ã现èå ã§çºçããè»éšèè «ã®äžçš®ã æªæ§æ«æ¢¢ç¥çµéè «çãšãåŒã°ããã
æªååïŒæªåé¡å€åœ¢æ§è»éšèè «*
çèãèèªãç¹ç¶çµç¹ãè¡ç®¡ããŸãã¯äœã®ä»ã®çµç¹ããçºçããããã
ç¡çæ§ãé çºæ§
ããã®äžçš®ã§ããã£ããæé·ãããã®ãæããŸãã
網èèœçŽ°èè «éºäŒåïŒRB éºäŒå
è «çæå¶éºäŒåã®äžã€ã
Soft tissue sarcomas: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 39
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modified, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
éœæ§åé€çž
ããæè¡ã®åé€åŸãæšæ¬ã®çµç¹èŸºçžã蟺çžãç çåŠè *ãçµç¹ã®ç«¯ã«è «ç现èãçºèŠããæ®
åè «çãããç¶æ ã
äºåŸ
ãã®çŸæ£ã®ãã©ããšæãããçµæãŸãã¯çµéïŒå埩ã®èŠèŸŒã¿ãŸãã¯åçº*ã®èŠèŸŒã¿ã®ããšã§
ãã
çåŠçæ³å£«
äœãå¥åº·ã«ä¿ã€ããã®å°é家ã§ãç æ°ãæªæã§ãäœåãèäœæŽ»åæ§ãäœäžããæ£è ããã®è©
䟡ãæ²»çãè¡ããçåŠçæ³ã®å 容ã¯ãéåããããµãŒãžããããããã¯ãã¢ã€ã¹ã€ã³ã°ãé»
æ°åºæ¿è£ 眮ã䜿ã£ãŠãçåäœäžãé€çãéåæ¹åãå³ããŸããæªæã®é²æ¢ãéåèœåäœäžã
äºé²ããèšç·Žãè¡ããŸãã
è¯æ§è «ç
ããã§ã¯ãªãããšãè¯æ§è «çã¯å¢å€§ããããšããããŸãããäœã®ä»ã®éšäœã«æ¡ããããšã¯ã
ããŸãããéæªæ§ãšãåŒã°ããŸãã
èšåºè©Šéš
æ°èŠæ²»çæ¹æ³ãæ²»çè¬ã®å®å šæ§ãæçšæ§ãæ€èšŒããããã«æ£è ããã察象ã«ããè©Šéšç 究ã
è¬å€ãæŸå°ç·æ²»ç*ãæè¡ã䜵çšæ²»çãè©äŸ¡ãããŸãã
ãªã³ãç¯
ãªã³ãçµç¹ã®äžžãå¡ã§ãåšå²ã¯çµåçµç¹ã®è¢«èã«èŠãããŠããŸãããªã³ãç¯ã§ã¯ãªã³ãã®æ¿Ÿ
éãè¡ãããŠããã»ãããªã³ãçã®è²¯èµå Žæã«ããªã£ãŠããŸãããªã³ãç¯ã¯ãªã³ã管ã«æ²¿ã£
ãŠååžããŠããŸãããªã³ãè ºãšãåŒã°ããŸãã
ïŒæªæ§ïŒãªã³ãè «
å ç«ç³»ã®çŽ°èããå§ãŸãããããªã³ãè «ã¯ 2 ã€ã«åé¡ãããŸãããããã¯ããªãŒãã¹ãã«
ã³ãã«ã°çŽ°èïŒReed-SternbergïŒç±æ¥ã®ããžãã³ãªã³ãè «ãšãå€çš®å€æ§ãªå ç«çŽ°èã®ç现
èãå«ãŸããéããžãã³ãªã³ãè «ã§ããéããžãã³ãªã³ãè «ã¯ãçµéã®ç·©æ ¢ãªæœåšæ§çµéã
ãšãå Žåãšãçºè²ãæ©ã䟵襲æ§çµéããšãå ŽåããããŸãããããã®ãµãã¿ã€ãåã«ããã
æ²»çãžã®ã¬ã¹ãã³ã¹ã¯ç°ãªããŸãã ããžãã³ãªã³ãè «ãéããžãã³ãªã³ãè «ãšãã«å°å ã
ãæ人ã«çºçããæ²»çæ¹æ³ãäºåŸ*ã¯ãç æãçã®ã¿ã€ãã«ããç°ãªããŸãã
ãªã³ãæµ®è «
äœåãªãªã³ã液ãçµç¹ã§å ç©ããèšåŒµããç¶æ ããããªã³ã管ãéå¡ãå·å®³ããããã¯æè¡
ã§é€å»ãããéãè ãäžè¢ã«çããå¯èœæ§ããããŸãã